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... To those who have dreams, but have doubts how to reach 
them…. Never give up, never get discouraged, just keep work hard 
and be dedicated to your dreams and life will reward you in the 
moment when you least expect this.   
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Abstract  
Organ failure is one the biggest problems, doctors face every day. Many 
patients are not able to get a transplant, but even those who recieved it, may 
undergo painful process of organ rejection and be on the transplant waiting list 
again. Organ transplants shortage is severe problem in current medicine that 
has many ethical and medical issues. To solve this problem, the new direction in 
regenerative medicine was formed, organ prinitng. The main goal of organ 
printing is fabrication of organ replacements that would mimic the original ones 
in terms of complexity and functionality. By direct fabrication and maturation of 
organs in vitro, the problem of organ shortage can be solved, moreover, based 
on the advances in cell therapy, these organs can be printed with patients own 
cells, which will eliminte the problem of transplant rejection.  
Organ printing is multistep and complex process, composed of three 
main steps: tissue design, or theoretical modelling of replacement composition; 
tissue fabrication, or direct cell encapsulation and controlled assembly of 
building units; at last, tissue maturation to reach desirable functionality of the 
replacement. In the past decade, there was developed a variety of methods for 
the second step of organ printing, cell encapsulation, which is practicaly the 
main procedure for tissue fabrication. However, all these methods of cell 
encapsulation are complex and they might affect cells viability and functionality, 
which will result in changed tissue function.  
Thus, starting from the detailed analysis of the tissue fabrication process 
(encapsulation and assembly methods) the list of possible cell behavior 
affectors was composed.  Based on this list, we designed a multistep protocol for 
coherent evaluation of cells behavior parameters, in terms of viability, 
functionality and activity during the tissue fabrication and its maturation steps. 
Three main materials were used for this study, two naturally (alginate and 
modified gelatin) and one synthetically (polyethilene glycol) derived polymers. 
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The encapsulation step was performed with two different methods based on 
chemical or photo crosslinking of the material. Cell parameteres were evaluated 
on the molecular level for variety of parameters, including viability, activity, 
proliferation, stress markers expression, at last ability to adapt artificial 
environment to the cell functional niche with extracellular matrix markers 
expression, and proteoglycans.  
The innovation of the presented study consists in the developing a 
unique protocol for detailed cell functionality evaluation during the organ 
printing procedures. In fact, based on the conducted study, it was proved the 
safety of the encapsulation methods. Moreover, based on the cell parameters 
post-encapsulation, there was suggested the optimal time for tissue maturation 
for application of the fabricated structures in organ printing, but also in other 
fileds, like developmental and pathological biology, or drug screening. Eventully, 
a novel way of simple blocks assembly into 3D complex structures was 
developed and proved to be safe for cell parameters.  
At last, for the future research in organ printing, a detailed study over a 
cell behavior and functionality has to be performed for every fabrication 
method, what will improve the organ production process drastically.  
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Chapter 1. 
General Introduction   
1.1 Tissue engineering: general terms  
1.1.1 Short history and definition of tissue 
engineering    
Tissue engineering (TE) as independent field of science was formed 
around 40 years ago, however the first historical note about tissue engineering 
can be found in Genesis I: 1: “The Lord, breathed a deep sleep on the man and 
while he was asleep he took out one of his ribs and closed up this place with 
flesh. The Lord God then built up into a woman the rib that he had taken from 
the man”[1]. Moving through the ages many references of TE applications were 
found. Recently, a women mummy was found aged around 3000 years which 
had a wooden toe prosthesis that replaced the amputated one [2].  In India in 
600 B.C. there was a first written reference about the rotational flaps 
application for reconstruction of amputated noses [3]. In Italy in 15-16th 
centuries many talented surgeons tried to improve the indian first version of 
rhinoplasty. Since that time, rhinoplasty procedure was drastically improved, 
however, the main principle remains the same as it was invented thousands of 
years ago.  
Around 30 years ago, the term tissue engineering was mainly referred to 
the use of prosthetic devices and the surgical manipulation of tissues. The first 
experiments in TE though were conducted in 1970th in Boston, city that may be 
considered as tissue engineering hometown. Unfortunately, first experiments 
were without a practical success but they gave valuable theoretical conclusion 
that with a proper combination of material and cells it can be possible to 
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generate a viable tissue. Based on this conclusion, couple of years later in 
Massachusetts Institute of Technology a group of scientists developed a novel 
skin draft by using collagen matrix and dermal fibroblasts. However, the real 
inception of current tissue engineering field started in mid-1980s by two 
talented scientists Dr. Joseph Vacanti and Dr. Robert Langer, when they came up 
with the idea of designing scaffolds for in vivo cell delivery. The results were 
unexpected and hardly explainable but they lay to the groundwork of the 
extensive research in the field of tissue engineering. Even though, in 1988 
during the meeting organized by National Science Foundation Tissue 
Engineering field was first introduced and described within the article of 
keynote presentation, till today the article that was published a little while after 
in 1993 in Science considered as the most-cited paper that describes tissue 
engineering discipline. In this paper Dr. Vacanti and Dr. Langer define Tissue 
Engineering as an “interdisciplinary field that applies the principles of 
engineering and life sciences toward the development of biological substitutes 
that restore, maintain, or improve tissue function or a whole organ” [4].   
Since the time those first small, but so valuable experiments were 
conducted, many scientific groups focused their attention on tissue engineering 
field and drastic progress was achieved.         
Thus, after many years of research scientists define the main goal of 
tissue engineering as production of suitable scaffold that would mimic natural 
tissue or organ for different applications like replacement or regeneration of 
tissues which were damaged due to trauma or disease; in vitro 3D models for 
drug screening and pathologies investigations.  
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1.1.2 Progress, current state and problems of 
tissue engineering 
During the first meeting in 1988 tissue engineering field was discussed 
as an alternative method for some injuries treatment by manipulating with 
prosthetic materials combined with existing tissues. The actual organ or tissue 
production using the basic concept of combining materials with cells wasn’t 
even considered at this memorable meeting, but since that time a lot has 
changed and significant progress was made in the field. One of the greatest 
scientists who made a priceless contribution in the field of tissue engineering is 
Dr. Anthony Atala and his group. At present his group is focused on growing 
tissues and organs of more than 30 parts of the body.  Back in 2006 in the 
Lancet journal Atala published his first results of human bladder 
transplantation in 7 patients and their post-operative control [5]. The results 
were very promising, all patients recovered from the surgery and were able to 
improve the quality of their lives significantly. Since that publication many more 
successful bladder transplantations were made. Great success was also made in 
some other areas like skin regeneration [6, 7, 8], cartilage and bone tissue 
engineering [9, 10], corneal regeneration [11] and in many other fields.  
Even though some tissues can be regenerated and grown back, there are 
still many unsolved issues in tissue engineering. Heart, liver, kidney and brain 
tissue engineering attracts the attention of many scientific groups, but the 
results are still on the intial stage. Some improvements were already done, but 
the day of engineered functional heart or kidney transplantation is not today. 
Brain engineering is even more complicated, brain work and organization is not 
completely understood by itself, what makes brain regeneration research even 
harder. However, heart seems quite well understood and well-studied organ, 
but its restoration and regeneration is not that easy as well, because of its 
structural complexity.  
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Each direction of tissue engineering like neural, cartilage or heart faces 
specific set of challenges that need to be solved, like cell source, scaffold 
modelling and proper biocompatible material selection, cell seeding and growth 
factors effect, following cell matrix analysis and mechanical testing, and finally 
animal testing before implementation on patients [2]. 
 
1.1.3 Tissue engineering approaches: 
advantages and open questions. 
Figure 1.1 represents two main approaches that generally used in tissue 
engineering. A major approach for in vitro tissue reconstruction has been called 
“top-down” which is mainly focused on the seeding cells of interest on top of the 
synthetic or natural polymeric scaffold, such as agarose [13], alginate [14], 
collagen [15], hyaluronic acid [16, 17], silk fibroin [18, 19, 20], poly (glycolic 
acid) (PGA) [21], and many others, following cells penetration through the 
scaffold from the top to the bottom. The idea, cells would homogeneously 
populate the scaffold and self-organize by mimicking in vivo conditions. The 
success of this approach has translated several engineered tissues to the clinical 
stage. However, despite many developed improvements in surface pattering or 
even use of biomimetic scaffolding, such as decellularized ECM templates, top-
down strategies often have  some limitations such as thick scaffolds 
vascularization, cell seeding density, large-scale tissues reconstruction, and 
finally, limited design of the intricate microstructural features of tissues [14, 
21]. 
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Figure 1.1: Tissue Engineering Approaches. Image adapted from R. 
Tiruvannamalai-Annamalai et al. [12].  
Bottom-up approach is based on the initial production of small cell-laden 
building blocks, which can be beads or capsules [12, 22], cell sheets or 
aggregates [23] or any other cell-laden structure and following assembly of 
these building units into more complex structures. This approach was invented 
to overpass the limitations of top-down approach, like weak control over 
scaffold composition, or vascularization. With bottom-up approach, building 
blocks can be prepared with different cell types and after guided to assemble in 
complex 3D structures by the variety of methods, like 3D bioprinting [5, 12, 27], 
magnetic [24], robotic [25] or acoustic self-assembly [26], stacking cell sheets 
and others in the precise order, mimicking in vivo organ structure.  
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1.2 Organ printing: challenges, steps and current 
state. 
Organ printing technology can be defined as biomedical application of 
rapid prototyping or layered additive biofabrication by using capable to self-
assemble cell-laden building blocks or cell aggregates [27, 28, 29, 30]. The 
fundamental principal of organ printing technology implicates tissue capability 
for fusion to closely placed cell aggregates or building blocks. This principal was 
taken from natural embryonic development, where fusion is very common 
event during the layers formation and body parts development [31].  
The ultimate goal of organ printing is large scale fabrication of 3D 
vascularized functional living organs for clinical transplantation and in vitro 
implementation for drug screening as well as platform for disease diagnostics 
[22, 24, 26, 29, 32]. Organ printing technology still has a lot of challenges, but 
with research and advanced improvements this developed technology will allow 
production of 3D functional living organs suitable for clinical implementation.  
Rapid prototyping is already well established and includes many methods such 
as stereolithography, selective laser sintering (SLS), fused deposition modeling 
(FDP), ballistic particles manufacturing (BPM) and others [29, 33, 34, 35, 36].  
The simplest way to describe the principles of organ printing is to use 
analogy of printing technology. In order to print a book it is necessary to have 
next essential components: written text, a printing press, movable type, paper 
and ink. So as with organ printing, it is necessary to have CT scan or MRI scan of 
the desired organ (Figure 1.2), that will be so called “blueprint”, a “bioprinter” 
or robotic dispenser, a cartridge or container for dispensing biomaterials mixed 
with living cells or cell aggregates, biodegradable biomimetic hydrogel to 
support the printed structure or “biopaper”, and self-assembling cell aggregates 
or single cells in hydrogels “bioink” [27, 29, 30, 37, 38, 39, 40].  
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Organ printing composed of three main steps (Figure 1.2) [37]. Proper 
parameters and material selection for each of this step are essential for success 
in the 3D structure fabrication. Dr. Mironov defined 10 top challenges in organ 
printing technology [29, 30]. Below all these challenges are described in terms 
of organ printing steps: pre-processing, printing and post-processing [30].  
 
 
Figure 1.2: Organ printing process composed of three main steps. Image 
adapted from Mironov et al [37].  
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1. Pre-processing is challenged by design, theoretical modeling and 
in silico tissue self-assembly of the desired organ. This is the first, and the most 
important set of challenges, without a precise design and theoretical modelling 
of cell behavior after printing, all the following steps will be useless. Initially 
obtained with computer tomography scanning picture of the organ can’t be used 
directly for organ printing. In silico tissue self-assembly will calculate and 
predict cells behavior, and which changes might happen during the organ 
maturation, such as cell fusion, shrinkage, matrix degradation by cells activity 
and many other parameters that have to be taken under control.  
2. Printing step or direct cell encapsulation and controlled 
placement in defined order is challenged by the proper selection of biopaper, 
bioink and bioprinter, which in biological terms refer to the proper selection of 
biomaterials, cell source and encapsulation or printing conditions. Bioink refers 
to the cell-laden building blocks [41, 42, 43]. As far as the fundamental principal 
of organ printing based on tissue fusion process, the building blocks has to be 
located and prepared in the way that would stimulate and guide tissue fusion 
[40]. Thus, cells functionality, so as materials properties (biopaper) will play 
here a critical role. Biopaper can be defined as biodegradable, biomimetic 
hydrogels specifically designed for the bioprinting process with tissue fussion-
permessive properties [31, 44, 45]. At last, bioprinter will have a crucial role on 
future 3D bioprinted organ. Bioprinter may affect significantly cell viability and 
vital characteristics during the following maturation step. Cell entrapment in 3D 
condition is stressful by itself, plus an effect of some encapsulation steps might 
affect cells viability, ability to proliferate and differentiate and many other 
characteristics might be affected, thus bioprinter selection so as direct 
encapsulation process has to be deeply evaluated before organ production.   
3. Post-processing, or organ maturation in bioreactors is important 
for future organ functionality, such as heart muscle contractions, or bone 
strength, neural signaling in brain tissue and so on [31, 38, 46, 47]. To obtain a 
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desirable behavior of printed organ it has to be placed in conditions that would 
mimic in vivo, like pressure, growth factors supply, stress resistance and others. 
At last, during the maturation process, so as before implantation or printed 
organ implementation its main parameters have to be evaluated in non-invasive 
monitoring. Viability, vascularization, main organ function have to be perfect, 
otherwise implantation of not properly prepared organ may cause severe 
complications [48].  
Even though organ printing technology faces many challenges, this is still 
feasible. In just a decade a dramatic success was made, meaning in the following 
decade even more will be accomplished. Many groups are working on these 
challenges and slowly move in the right direction to overpass these 
complications and finally be able to print functional living organ.  
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1.3 Cell encapsulation  
1.3.1 General introduction.  
In 1933 Bisceglie made a simple experiment, he enclosed tumor cells in 
polymer membrane and implanted them into pig’s abdominal cavity. Results 
showed, that cells survived long enough, to make a conclusion that immune 
system didn’t damage or destroy them [49, 50, 57]. Three decades later Chang 
introduced cell encapsulation as promising method for protecting cells from 
immune aggressiveness by encapsulating them in ultrathin polymeric 
membranes, and subsequently evoked term “artificial cells” [51]. This idea was 
widely applied in 70-80th for diabetes control in small animals by immobilizing 
xenograft islet cells. Since then, a dramatic progress was made in understanding 
materials science, immunology, genetics and pharmaceutical technology that 
are so crucial for successful cell encapsulation [49]. Microencapsulation found 
many applications in different fields, such as therapeutic treatment for diabetes, 
cancer, hemophilia and renal failure [50, 52, 53], stem cell research [22] and 
others [54, 55, 56]. Around a decade ago, cell encapsulation received enormous 
scientific attention as the main method for the second step of organ printing 
technology, as it described above.   
Cell encapsulation methods consist in the entrapment of cells in 
microcapsules or microbeads starting from a suspension of cells in polymeric 
solution that can be solidified by chemical or physical methods [50-57]. 
Generally cell encapsulation involves fabrication of three-dimensional (3D) 
scaffolds, with either seeded cells on top or with cells directly encapsulated with 
aim to use this fabricated 3D structure for healthy replacement of damaged 
tissues, or for guidance and support for tissue recovery.  
Cell microencapsulation is a technology that has tremendous potential in 
the field of tissue engineering and regenerative medicine for regeneration, 
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restoration but also for transplantation and substitution of damaged or diseased 
tissues and organs. 
1.3.2 Methods for cell encapsulation 
With microencapsulation methods cells can be entrapped in various 
controllable forms such as beads, sheets, or fibers [52, 57]. In the recently 
published review Gasperini [52] described main cell encapsulation strategies 
that are widely used. Table 1 summarizes and compares several cell 
encapsulation techniques according to the final scaffold size and shape, but also 
the scalability of these methods and type of gelation mechanism applied for 
encapsulation.  
 
Name 
Control of 
size 
Minimum 
Size (d in 
µm) 
Size 
dispersion 
Best gelling 
mechanism 
Extrusion  Medium 80 
Medium/ 
Low 
Fast/ 
Ionotropic 
Lithography Very good 50 Low All 
Emulsion Low 10 
High/ 
Medium 
Thermal 
Microfluidic Very good 50 Low All 
Bioprinting Very good 100 Low 
All (more 
complex with 
thermal) 
Superhydrophobic 
surfaces 
Very good 1000 Low All 
 
Table 1.1: Cell encapsulation strategies [52-66]. 
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1.3.2.1 Extrusion methods and state of the art.  
The simplest and the most applicable method for cell encapsulation is 
extrusion [52, 56, 57, 58, 59]. This method is based on gravitational dripping 
properties of liquids. The suspension of pre-polymer solution mixed with cells 
extruded through the syringe or a needle. On the top of the needle drops form 
and when they reach a critical mass they fell freely in the collecting bath with 
the crosslinking solution. The final size of beads fabricated with extrusion 
methods depend on many factors, such as ionic concentration of the 
crosslinking bath, the surface tension of the drop, and the diameter of the 
pendant droplet neck [22, 52, 60]. Generally, the beads size is around 1mm, and 
the shape of the beads is not perfectly spherical, but rather droplet-like shape.  
Many extrusion methods were advanced for obtaining the control over 
the final scaffold or bead size and shape, but also for improving cell viability and 
functionality [61, 62, 63]. For example, wet spinning, was modified extrusion 
method for final fabrication of fibers instead of beads. This method allows 
production of fibers, by extruding pre-polymer solution directly into the 
collecting bath with crosslinking solution without an air gap between the needle 
and a bath.  
One else example of extrusion method modification is for generation of 
smaller size beads with controllable shape [52, 62]. The idea for production of 
smaller beads is to break down the extrusion jet before the drop will reach the 
critical mass and fells by itself. One of the applying methods is coaxial air flow 
[54, 62]. This method applies a compressed gas that directed through the 
extruding droplet and it causes the drop detachment faster than the droplet 
critical mass is reached. In the same mechanism beads can be produced but 
implying another liquid instead of gas.  
Another advanced and precise method of small beads formation is 
vibrational encapsulation [65]. This system is based on the concept that liquid 
jet extruded from the orifice of the needle will be broken down into the equal 
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size droplets by applying vibration to the nozzle. By manipulating with flow and 
vibration parameters it is possible to obtain beads size around 100 µm.  
At last, by applying an electrical charge to the extruding needle it is also 
possible to obtain smaller beads with controlled size, by so-called bio-
electrospraying method [22, 52, 60, 62, 66]. The extruding droplet reacts to the 
presence of electrical charge by accumulating ions of opposite sign on its 
surface. As the result, ions accumulation creates stress that force droplet to 
detach from the needle and drop into the crosslinking bath [66].  
 
1.3.2.2 Lithography-based methods 
Lithography methods include two subtypes: stereolithography and 
photolithography [41-43, 50, 52, 55, 56, 62, 67, 68, 69]. Stereolithography is 
based on the hydrogels production using replica moulding. At first, replicas 
produced by spin-coating or pouring and following UV crosslinking. Next, 
replicas filled with cells suspended in prepolymer solution and exposed to UV 
light hydrogel crosslinking [67].  
Photolithography is another widely applied method for cell encapsulation and 
based on using photo-mask that placed on top of the photocrosslinking material 
mixed with cells [68]. Photo mask can be designed to produce a hydrogels in 
variety of sizes and shapes. But also, the hydrogels can be produced with 
different cell types by mimicking tissue/organ complexity. This strategy is 
widely used for 3D model fabrication for diseases investigation or general 
science. There are several important requirements for fabrication of patterned 
biocompatible cell-laden hydrogels by photolithography [41, 42, 43, 68, 69]. 
First requirement is proper photocurable material amenable to polymerization 
caused by photosensitive free radicals. Another important requirement is 
photoinitiator (PI), that must not only initiate the reaction, but also eliminate 
the reaction as soon as UV light exposure is stopped, but most importantly for 
17 
 
tissue engineering application, it has to have low cytotoxicity. A separate 
attention must be paid for combination of factors like UV time exposure during 
photopolymerization, and PI concentration, both these factors can affect cell 
viability.  At last, a photomask is important as well, it has to be made in the way 
to protect unwanted areas from UV light, and those that exposed, has to be 
permeable for UV rays and initiate the crosslinking. 
Polymer networks can be synthesized using various chemical methods, 
such as photo-, chemical, mechanical- or thermal-initiated polymerization. 
Advances in materials science made it possible to design and synthesize 
polymer networks with molecular-scale control over the structure such as 
crosslinking density and with tailored properties, such as biodegradation, 
mechanical strength, and chemical and biological response to stimuli.  
 
1.3.2.3 Emulsion-based methods 
Fabrication of spherical capsules by emulsion-based method found a 
wide application in pharmaceutical industry [53, 70, 71].  This strategy is based 
on the mixing of two liquids that are immiscible (for tissue engineering 
application one of the liquids is hydrogel precursor), the surfactants applied to 
the mixture will stabilize the emulsion and allows preparation of smaller 
droplets. After the suspension reaches the equilibrium precursor droplets 
undergoes sol-gel transition and become solid [26].  
1.3.2.4 Microfluidics-based methods 
 Microfluidics methods are based on the manipulations with small 
volumes of liquids in microenvironments as microchannels on chips [52, 54, 70, 
72-78]. Droplets fabrication mechanism has similarity with emulsion 
encapsulation system, but this process happens in microenvironments and 
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applying flow of liquids to control the shape and size of produced 
microdroplets. Droplets that fabricated by microfluidics can be considered as 
bottom-up manufacturing, whereas the classical emulsion approach is top-
down. The generation of microfluidics droplets happens through injecting the 
mixture of hydrogel precursor and cells into a microchannel and the droplets 
form when it reaches the continuous phase of non-miscible solution coming 
from the other inlets.   
1.3.2.5 Bioprinting-based methods 
3D bioprinting idea was taken from the paper printing technology. Like 
industrial printing technology had a revolutionary effect on people education, 
politics, religion and language across the globe, 3D printing affects dramatically 
science and research. Using 3D printing technology archeologists reproduce 
replicas of ancient and rare artifacts or some fossils for art, education and 
exhibitions. This technology allows design and work with three-dimensional 
spatial models [27]. But one of the most important applications 3D bioprinting 
found in organ or tissue fabrication.  
3D bioprinting is layer-by-layer additive robotic positioning of biological 
materials mixed with cells and growth factors, with spatial control over the 
placement of functional components with aim to produce a 3D functional organ 
or tissue substitute. As showed in Figure 1.3 [27] ioprinting is complex 
procedure that composed of important steps, only proper performance of which 
can result in a successful organ/tissue fabrication. The main challenge of 3D 
bioprinting is reproduction of complex micro-architecture of extra-cellular 
matrix (ECM) components and multiple cell types in sufficient resolution to 
recapitulate biological function.  
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Figure 1.3: Bioprinting steps from the initial 3D computer modelling to 
the tissue printing and maturation. Images adapted from Atala et al [27]. 
There were developed many biofabrication technologies such as organ 
printing or directed tissue self-assembly, solid scaffold-based biofabrication, 
embedding and molding technology, cell sheet technology, digital and inkjet 
bioprinting and many others [27-28, 32, 39, 40, 79, 80].   
1.3.2.6 Superhydrophobic surfaces based 
methods 
This strategy based on the simple principle of some materials 
hydrophobicity [69, 81].  By placing a drop of water on the hydrophobic surface 
it will remain in the droplet shape. Thus, cells mixed with water-based hydrogel 
precursor can be dripped on the superhydrophobic surface and crosslinked or 
dried through the contact with air or any other desirable surrounding 
conditions, and the surface contact will allow to keep the shape of drops [52].   
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1.3.3 Material selection for cell encapsulation 
Cell encapsulation process starts from the suspension of buffer-based 
pre-polymer solution with cells, so called the sol flowing phase. After applying 
chemical, physical or biochemical stimuli liquid pre-polymer solution undergoes 
a transition to gel form, so called non-flowing phase. All the stages of sol-gel 
transition have to be well adjusted for cell viability, means they have to be as 
close as possible to the cell physiological conditions [52, 82, 83, 86, 87]. Over the 
years of materials studying and application of cell encapsulation for organ 
printing technology, list of desirable materials properties become well-formed 
and clear. Materials for cell encapsulation must have suitable crosslinking 
mechanism for successful encapsulation process, biocompatible but most 
importantly it has to support cells viability, activity, proliferation and main 
functions [22, 24, 43].  
 
Figure 1.4: Cell microencapsulation: nutrients, oxygen and stimuli diffuse 
across the membrane, whereas antibodies and immune cells are excluded. 
Image adapted from Gorka O. et al [50]. 
Another crucial requirement is suitable short-term stability together 
with mechanical, physical properties. But also, it has to have a proper porosity 
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characteristics, depends on the future application [84]. It has to be supportive 
for inflowing nutrients, oxygen and growth factors, and outflowing toxic waste 
products and cells activity products, for example insulin for diabetes treatment 
encapsulated cell delivery [82]. But, crucially it has to protect cells against 
antibodies and immune cells penetration, for cell protection inside the beads 
[84]. The ideal bead/ hydrogel schematically presented in Figure 1.4.   
Materials currently used in the field of tissue engineering for 
regeneration and repair are mainly naturally derived polymers, such as alginate 
[14, 82, 83, 102], gelatin and its modifications [86, 90], collagen [15, 87], silk 
fibroin [18, 19, 20, 88], hyaluronic acid [16, 17, 89]; but there are also synthetic 
polymers that are widely used for some applications, such as  PGA, polyethylene 
glycol (PEG) [21, 91, 92]. Both of the material types have its advantages and 
disadvantages. Natural polymers have similar to human extra cellular matrix 
(ECM) composition and structure [93, 94, 95, 96]. They are also very 
biocompatible and supportive for cells growth and activity. Whereas synthetic 
polymers have good repeatability characteristics and good control over 
gelation, degradation processes. Another advantage of synthetic polymers, that 
they can be easily modified or tailored to reach desirable mechanical or physical 
properties, which is complicated with natural polymers [27]. However, 
synthetic polymers generally have poor biocompatibility characteristics, toxic 
metabolites and loss of mechanical properties during degradation.  
The most commonly used and well described synthetic polymers with 
neutral properties are polyethylene glycol (PEG) [91, 92], poly (hydroxyethyl 
methacrylate) (PHEMA) [97, 98, 99], and poly (vinyl alcohol) (PVA) [99, 101]. 
PEG hydrogels are non-toxic, non-immunogenic and number one used FDA 
approved for biomedical application. PEG hydrogels can be covalently 
crosslinked through covalent bonding using variety of methods. Photo initiated 
crosslinking using acrylate-terminated PEG monomers is the most applicable 
method for PEG hydrogels formation. Cell-laden PEG hydrogels are inert, since 
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they are prevent protein adsorption.  Because of easy manipulation and 
inertness properties, PEG polymers were modified in different ways for cell 
application to improve adhesion and proliferation, for example peptide 
sequence was incorporated into PEG structure to induce degradation, and cell 
adhesion [43]. 
PHEMA is another hydrogel that has been extensively studied and used 
in biomedical applications such as contact lenses and drug delivery. PHEMA 
hydrogels have good mechanical properties, optical transparency, and stability 
in water. PHEMA hydrogels are easily modified as well, to modulate the 
properties for different applications [97, 98, 99].  At last, PVA is another 
synthetic polymer. PVA hydrogels are stable, with crosslinks through the 
repeated thawing-freezing procedure or chemically crosslinked [99, 101].  
Another group of polymers are naturally derived, such as collagen, silk, 
hyaluronic acid (HA), agarose, alginate, or gelatin and their modifications [13-
20, 43]. Depending on their origin and composition, these materials can be 
applied for different applications. An advantage of natural polymers over 
synthetic is their natural low toxicity and biocompatibility.  
Collagen and other mammalian cell derived protein-based polymers are 
effective matrices for cellular growth because they contain many cell-signalling 
domains present in vivo ECM. Collagen hydrogels can be easily obtained 
through the thermal crosslinking at 37°C degree, however they have relatively 
weak mechanical properties.  Thus, many modifications were done with 
collagen that improved their mechanical characteristics, and crosslinking 
process.  
HA is glycosaminoglycan (GAG) that is composed of repeated 
disaccharide units, and most abundant in wound healing and in joints, however 
it is still can be found in all cells types, but in less amount.  
Ali Khademhosseini group hypothesized and proved the idea of using 
GelMA for micropatterened 3D hydrogels fabrication. As it was earlier 
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described, cell entrapment in GelMA hydrogels showed good results in cells 
long-term viability, and high proliferative potential [103, 104]. Thus, his group 
made an advanced study over 3D hydrogel binding surface, cells elongation and 
migration within the GelMa hydrogels. And they demonstrated that GelMA 
allows rapid cell adhesion, cell phenotype elongation, high proliferation 
potential, and migration in 2D and 3D. GelMA is promising material for variety 
of applications in tissue engineering [90, 105].         
Another advanced research over GelMA application was made within Ali 
Khademhosseini group, by mixing GelMA with the FDA approved and described 
above PEG polymer [105]. By mixing these two polymers they wanted to obtain 
highly biocompatible, non-toxic, mechanically stable and easily manipulated 
hydrogel for cell encapsulation and micro patterned 3D hydrogels fabrication. 
Thus, they synthesized a mixed of PEG/GelMA hydrogel that is inexpensive, 
easily produced, and most importantly biologically and mechanically tunable.  
 
1.3.4 Cell source for encapsulation  
Organs and tissues are complex and composed of many different cell 
types and in various combinations. Immune rejection complications after 
transplantation makes cell source one of the main challenges for successful 
organ printing. Patient’s embryonic cells (ECs) will the best cell source for any 
tissue engineering application, because of its potential to differentiate in any cell 
type of the body [106-114]. However, in many countries ESCs therapy is not an 
option because of the ethical reasons, as well as for adults autologous ECs are 
out of reach. An advance solution to this problem was found by the Japanese 
professor Yamanaka and his Nobel Prize for discovery of induced pluripotent 
stem cells [115, 116]. These reprogrammed stem cells mimic ESCs, but not 
identically, in terms of morphology, proliferation, gene expression, surface 
markers and teratoma formation [5, 117]. Many groups today work on different 
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protocols for induction of pluripotent stem cells [118, 119, 120, 121, 122, 123]. 
These cells can solve both complications: differentiation potential and immune 
inertness. In many cases less potent autologous stem cells can be a suitable 
source for tissue engineering, exception will be perfect when patience cells are 
damaged or patient doesn’t have enough cells for therapy. Mesenchymal [124, 
125], adipose [126, 127], blood, bone marrow derived stem cells [128, 129] are 
the most commonly used source for adult autologous transplantation and tissue 
engineering. The variety of stem cells that can be used for tissue engineering 
purposes is presented in Figure 1.5.  
Any cell type chosen for cell encapsulation as building blocks for organ 
printing, has to have a high proliferation potential, to reach sufficient amount of 
cells for transplantation. Precise control over differentiation and proliferation in 
vitro and more importantly in vivo, is crucial for cell encapsulation. As it was 
mentioned above ECs and iPSCs are capable of teratoma formation which has to 
be eliminated and controlled.  Too slow proliferation rate may result in the loss 
of viability and as a result cell death, whereas too high rate may cause 
hyperplasia and apoptosis. Timing for cell proliferation important as well, initial 
high cell proliferation rate is important to reach a proper cell density. But after 
some time the rate has to be equal to in vivo conditions to achieve cellular 
homeostasis, albeit without hyperplasia. This can be controlled with growth 
factors delivery, in some cases viral transfection is used for control over cell 
proliferation and senescence.  
Thereby, cell selection faces next set of challenges: well-understood and 
characterized, easily reproducible cell source; proper cell type combinations 
which would closely mimic natural conditions; strict control over cells 
differentiation and proliferation. 
25 
 
 
 
1.5: Stem cell source for tissue engineering applications. Image adapted 
from Lutolf et al [130]. 
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1.4 Building blocks assembly techniques for 3D 
tissue engineering.  
Human tissues and organs are complex, some of them like skin, or 
bladder are relatively simply organized, with small variety of cell types 
composed in the formation of these organs, whereas heart, kidney, and least 
understood brain are very complex, many different cells compose these organs 
and participate in the proper functioning. For example brain is composed of 
over 1 billion of different types of neurons, and 10 to 50 times more of glial cells, 
that act as servants for proper neural work (Figure 1.6) [131, 132]. 
 
 
Figure 1.6: Different Types of Neurons. A. Purkinje cell B. Granule cell C. 
Motor neuron D. Tripolar neuron E. Pyramidal Cell F. Chandelier cell G. Spindle 
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neuron H. Stellate cell. Images adapted from Ferris Jabr; based on 
reconstructions and drawings by Cajal [131]. 
The complex tissue organization makes tissue engineering field is very 
challenging. As it was described above in section 1.4 there are many ways to 
fabricate cell-laden hydrogels in different shapes and sizes for variety of 
applications. However, many of them are capable of producing small size 
hydrogels, and more importantly they are limited to encapsulation of the poor 
variety of cell types into one hydrogel, which in many cases will be a serious 
limitation for tissue/organ fabrication [33, 34, 35, 36, 133, 134, 135, 136, 137].  
Thus, properly prepared and laden with different cell types hydrogels 
have to be assembled in more complex structure that would mimic in vivo tissue 
in size and complexity. 
Assembly of cell-laden building blocks found an emerging application in 
tissue engineering and regenerative medicine, but also for drug screening on 
complex 3D models fabrication. Assembly approaches are focused on enabling 
rapid and scalable fabrication of engineered tissue substitutes with controllable 
and predefined geometrical, biological features and complex architecture [33, 
34, 35, 36]. The assembly idea was taken from the nature where assembled and 
repeated units are quite common, for example nephrons in kidney, lobules in 
liver, DNA assembly from nucleotides and protein splicing and assembly from 
RNA units. Inspired by nature, many research groups developed different 
approaches for cell-laden hydrogels assembly, such as acoustic, magnetic, 
robotic, or even bioprinting can also considered as technique for hydrogels 
assembly by direct printing of them, some of these approaches illustrated at 
Figure 1.7. 
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 Figure 1.7: Directed assembly methods in literature for microscale 
hydrogels. A) Microfluidics assembly; B) Acoustic assembly; C) Magnetic 
assembly; Images adapted from Gurkan et al [33]. 
1.4.1 Magnetic and paramagnetic assembly 
Magnetic fields have already found an application for cell sorting and 
isolation, in vivo imaging, and 3D cell culture [33]. Recently, magnetic field 
found an application for construction of 3D tissues. Hydrogel manipulation 
strategies using magnetic fields appear to be various, contactless and 
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inexpensive. There are some ways of producing hydrogels or building blocks 
with magnetic properties. The most common and originally proposed was 
loading hydrogels with magnetic nanoparticles of different kind, such as gold, 
iron oxide or bacteriophage. However, magnetic nanoparticles are potentially 
dangerous because of tissue cytotoxicity. Thus, new approaches that do not 
require nanoparticle presence are in great demand. Tasoglu and his group 
developed a new method for magnetic assembly by loading hydrogels with free 
radicals and vitamin E. These easy modifications allowed to perform guided 
self-assembly of materials with heterogeneous properties such as porosity, 
mass density and stiffness into the 3D structures [24, 34, 133, 134].  
1.4.2 Acoustic assembly  
 
 
Figure 1.8: Building units assembly using acoustic waves. A) Diversity of 
structures created by liquid-based templated assembly. B) Liquid-based 
templated assembly for tissue engineering. Images adapted from Chen et al [26]. 
Acoustic fields have been used for in vivo imaging in medicine for quite 
some time, lately it has been applied in many other fields like particle 
 
B  
 
A 
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microcentrifugation, aggregation and trapping, cells manipulations like sorting 
and separation, and droplet concentration and mixing [26, 33, 135, 136].  
Recently, acoustic field was applied for hydrogels assembly in bottom-up 
tissue engineering technology. This approach is based on the acoustic waves 
properties to organize cells or hydrogels of different size and weight on 
different layers of places. This approach shows high cell biocompatibility and 
versatile final structure manipulation as it shown in Figure 1.8 [26]. 
 
1.4.3 Robotic assembly 
In the present world more and more fields are becoming mechanized, 
means industry is trying to use machines instead of humans work. This allows 
fabrication of many products in large-scale and in short time. Tissue 
engineering technology as well tries to mechanize the process of tissue/organ 
fabrication in many different ways. One of them is hydrogels self-assembly using 
micro-robots [36, 137].  
 
 
Figure 1.9: Micro-robotic assembly of versatile in shape and size 
hydrogels: A) Two-dimensional micro-robotic coding of material composition. 
A B 
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B) Spatially coded constructs for tissue culture. Images adapted from Tasoglu et 
al [36]. 
 Magnetic levitation described in the above chapter is easy and cheap 
method for tissue assembly, however it has low precision over the assembly 
process. Microfluidics assembly, or multilayered crosslinking methods have a 
high precision over the assembly process, but just few of them might have a 
precision of ten microns in the hydrogels assembly, and definitely none of them 
can perform reassembly of the building blocks. Dr. Tasoglu and his team 
developed a versatile method to guide and manipulate assembly of building 
blocks into 2D and 3D complex functional structures using untethered magnetic 
micro-robots. The process of micro-robotic assembly presented in the Figure 
1.9. This approach offers high precision over the 2D and 3D assembly, but also it 
allows application of a combination of soft and rigid materials together.  
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Chapter 2. 
Research strategies and objectives 
2.1 Thesis rationale    
In the previous chapter there was introduced the concept of tissue 
engineering, its main approaches, advantages and open questions. After, there 
was presented a concept of organ printing with particular attention to its 
second step, cell encapsulation. There were described many methods for 
scaffolds or beads fabrication with focus on their complexity, proper cell type 
and material selection. At last, there was described in details a review on the 
cutting edge technology of building blocks assembly methods for complex 3D 
structures fabrication.   
The final objective of the presented research work was detailed analysis 
of the organ printing strategies impact on cells viability, functionality and ability 
to maintain homeostasis in artificial conditions during the encapsulation 
process with following self-assembly into 3D complex structures (as the second 
step of organ printing), and during the tissue maturation period (as the third 
step of organ printing).  
Cell encapsulation is the main method for the second step of organ 
printing, hence there were developed variety of different ways to produce cell-
laden units. However, all of them are complex and multistep, thus might be 
harmul for cell behavior and functionality during the encapsulation process, but 
most importantly it might affect the cell behavior during the maturation 
process. Based on the possible cell functionality affectors such as heat, shear 
stress, chemicals and UV light exposure in the applied methods, we designed a 
protocol for detailed evaluation on the molecular level of the cells stress state, 
viability and functionality after encapsulation within short and long-terms [22]. 
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Furthermore, different tissue engineering applications have set of crucial and 
unique requirements for fabricated structures that have to be met. Based on this 
knowledge, we evaluated the optimal maturation time referring to cells activity 
and functionality for variety of applications, such as organ printing, drug 
screening and 3D disease models. At last, we developed a simple contactless 
method for self-assembly of fabricated building blocks into 3D structures to 
mimic the tissue complexity, and evaluated its effect on cell behavior 
parameters.  
In the presented research work, different techniques and materials were 
used to evaluate the most favorable and safe conditions for functional 3D living 
microtissues fabrication.  
In the next section materials, structures and setups introduced and 
decribed.  
2.1.1 Building units fabrication 
2.1.1.1 Materials  
To reach the main goal of the presented work there were used two 
natural polymers: alginate, gelatin methacrylate, and one synthetic polymer 
polyethylene glycol (PEG).  For the levitational assembly part there were also 
used manufactured beads modified for cell application.  
Alginate 
One of the most commonly used materials for cell encapsulation is 
alginate, due to its easy ionic crosslinking, biocompatibility and mechanical, 
physical properties. Alginate is a polysaccharide that is extracted from the 
different types of seaweed, but also it produced by two types of bacteria, 
Pseudomonas and Azotobacter [52].  
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Figure 2.1 Sodium alginate structure. Image adapted from Lee at al [82]. 
Alginate composed 2 copolymeric blocks of (1,4)-linked β-D-mannuroic 
(M block) and α-L-guluronic (G block) acids as it showed in Figure 2.1 [52, 82].   
The crosslinking process of sodium alginate happens upon the contact with 
multi-valent cations (Ca2+), they bind adjacent sodium alginate chains forming 
ionic interchain bridges (Figure 1.4.3)   
 
Figure 2.2: Sodium alginate sol-gel transition upon the contact with Ca2+ 
cations.  
Alginate is lack of cell adhesion motifs, though a lot of research was done 
in tailoring alginate with RGD peptides sequence, which is crucial for cell 
adhesion and differentiation [102].  
Alginate characterized as a material with a wide range distribution of 
pore size (5-200 nm), which depends on the initial sodium alginate percentage 
composition of M and G blocks. G blocks are responsible for bigger pore size as 
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well as for hydrogels rigidity and mechanical properties. But also, there was 
found a strong correlation between the alginate permeability and crosslinking 
ions; higher the concentration of cations, creates tighter alginate structure, 
especially on the outer part of hydrogel which is in direct contact with 
crosslinking solution.  
The other very important characteristic of alginate, it’s the ability to 
dissolve in vivo condition, as a result of bivalent ions exchange with monovalent 
ions from the body liquids. It will gradually dissolve calcium alginate, and 
transform it back to sodium alginate which is not degradable in vivo.       
Alginate has become one of the most studied materials for cell 
encapsulation, and widely used. It was adjusted and modified for many different 
applications, such as immunoprotection of pancreatic islets, treatment of brain 
tumours, treatment of anemia and cryopreservation [52, 82, 102].    
 
Gelatin methacrylate (GelMA) 
The profound attention in photolithographical cell encapsulation 
received naturally-derived polymer gelatin, modified with methacrylate sites 
[103]. As it presented in Figure 2.3, gelatin was chemically modified with 
methacrylic anhydride, to obtain functional sites for photo crosslinking. Gelatin 
methacrylate (GelMA) is a photopolymerizable hydrogel comprised of modified 
natural ECM components, what makes it biocompatible and promising material 
for tissue engineering application.  
Gelatin is inexpensive, denaturated collagen that can be derived from a 
variety of sources, it contains natural cell binding sites, such as RGD, and at the 
same time rich in MMP-sensitive degradation sites [103]. Chemical modification 
with methacrylic anhydride makes GelMA light polymerizable into a stable at 
37°C hydrogel.  
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Figure 2.3: Synthesis of methacrylated gelatin. Gelatin macromers 
containing primary amine groups were reacted with methacrylic anhydride 
(MA) to add methacrylate pendant groups (A). To create a hydrogel network, 
the methacrylated gelatin was crosslinked using UV irradiation in the presence 
of a photoinitiator (B). Images adapted from Nichol et al [103]. 
 
Polyethylene glycol (PEG) 
Polyethylene glycol s a polyether compound with many applications from 
industrial manufacturing to medicine. The structure of PEG is (note the 
repeated element in parentheses): H-(O-CH2-CH2)n-OH.  
PEG hydrogels are non-toxic, non-immunogenic and number one used 
FDA approved for biomedical application. PEG hydrogels can be covalently 
crosslinked through covalent bonding using variety of methods. Photo initiated 
crosslinking using acrylate-terminated PEG monomers is the most applicable 
method for PEG hydrogels formation. Cell-laden PEG hydrogels are inert, since 
they are prevent protein adsorption.  Because of easy manipulation and 
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inertness properties, PEG polymers were modified in different ways for cell 
application to improve adhesion and proliferation, for example peptide 
sequence was incorporated into PEG structure to induce degradation, and cell 
adhesion [34, 43, 91, 92]. 
 
Figure 2.4: Polyethylene glycol structure.  
 
2.1.1.2 Cell encapsulation methods 
Electrohydrodynamic jetting  
A custom-designed electrically insulated holder was placed under a 
biological hood. Sterile 3 mL syringe was filled with cells suspended in the 
alginate solution, connected to a polytetrafluoroethylene tube and placed on the 
pump set to a fixed flux of 0.05 mL/min. The other side of the tube was 
connected to a stainless steel needle and placed in the holder under the hood. 
The positive cathode of a generator (ES30, Gamma High Voltage Research Inc, 
USA) was connected to the needle while the anode was connected to a metallic 
plate placed under a Petri dish containing the sterile calcium chloride solution 
and placed below the needle at a distance of 5 cm. Once the flux of solution was 
established and the generator was switched on (V=8kV), droplets of alginate 
solution containing cells were ejected from the needle directly to CaCl2 solution. 
After 10 minutes the beads were washed three times with full cell culture media 
and redistributed in 6-well tissue culture plates to perform the experiment [60]. 
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Figure 2.5: Electrohydrodynamic jetting encapsulation system. A. 
Encapsulation scheme; B. Beads view without cells; C. Beads with cells; D. 
Live/Dead analysis of cells encapsulated in the beads. 
Photolithographic crosslinking system  
Photolithography is another widely applied method for cell 
encapsulation and based on placing a photo-mask on top of the 
photocrosslinking material mixed with cells [34, 41, 42, 43, 68, 90, 104, 105, 
106]. Photo mask can be designed to produce a hydrogels in variety of sizes and 
shapes. But also, the hydrogels can be produced with different cell types by 
mimicking tissue/organ complexity. This strategy is widely used for 3D model 
A 
Live/Dead 
B 
C 
D 
Scale bar: 100µM  
Scale bar: 200µM  
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fabrication for diseases investigation or general science. 
 
 
Figure 2.6: Photolithographic encapsulation system [34]. 
Photolithographic encapsulation system. A. Encapsulation scheme; B. Hydrogel 
view with encapsulated cells; C. Live/Dead analysis of cells encapsulated in the 
hydrogel.  
There are several important requirements for fabrication of patterned 
biocompatible cell-laden hydrogels by photolithography [42]. First requirement 
is proper photocurable material amenable to polymerization caused by 
photosensitive free radicals. Another important requirement is photoinitiator 
(PI), that must not only initiate the reaction, but also eliminate the reaction as 
soon as UV light exposure is stopped, but most importantly for tissue 
engineering application, it has to have low cytotoxicity. A separate attention 
must be paid for combination of factors like UV time exposure during 
photopolymerization, and PI concentration, both these factors can affect cell 
viability.  At last, a photomask is important as well, it has to be made in the way 
to protect unwanted areas from UV light, and those that exposed, has to be 
permeable for UV rays and initiate the crosslinking. 
  
Hydrogel Fabrication Process  
Scale bar 200 µm 
Encapsulated Fibroblasts 
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2.1.1.3 Magnetic levitational assembly 
Magnetic levitation is contactless and nanoparticle-free approach for 
tissue self-assembly [24, 34, 133, 134]. This method is based on the idea of 
levitating subjects in paramagnetic suspension. Salt ions of gadolinium (Gd3+) 
and magnesium (Mn2+) or radicals have paramagnetic properties. Cells were 
encapsulated in photo-crosslinkable polymers of gelatin (GelMA) and 
polyethylene glycol diethacrylate (PEGDA) and levitated in the media 
suspension with ions of Gd3+ salt. This approach shows high scaling potential, 
good cell viability and functionality, but also easy to manipulate and guide the 
hydrogels assembly makes it very promising for bottom-up tissue engineering.   
 
 
 
Figure 2.7: Paramagnetic levitational assembly of PEGDA hydrogels. A-H) 
Concentric assembly of two hollow-disks and a solid-disk PEG gel. Images 
adapted from Tasoglu et al [34]. 
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2.1.2 Cells 
In this work two main cell lines were used: m3T3 and hSHSY5Y.  
2.1.2.1 NIH3T3  
NIH 3T3 mouse embryonic fibroblast cells come from a cell line isolated 
and initiated in 1962 at the New York University School of Medicine Department 
of Pathology. 3T3 refers to the cell transfer and inoculation protocol for the line, 
and means “3-day transfer, inoculum 3 x 10^5 cells.” Using this protocol, the 
immortal cell line begins to thrive and stabilize in cell culture after about 20-30 
generations of in vitro growth. The cell line has since become a standard 
fibroblast cell line and one the most commonly used cell models for tissue 
engineering methods testing.   
2.1.2.2 SHSY5Y  
SH-SY5Y is a human derived cell line used in scientific research. The 
original cell line, called SK-N-SH, from which it was subcloned was isolated from 
a bone marrow biopsy taken from a four year-old female with neuroblastoma. 
SH-SY5Y cells are often used as in vitro models of neuronal function and 
differentiation. The cells typically grow in tissue culture in two distinct ways. 
Some grow into clumps of cells which float in the media, while others form 
clumps which stick to the dish. SH-SY5Y cells can spontaneously interconvert 
between two phenotypes in vitro although the mechanisms underlying this 
process are not understood. SH-SY5Y has a dopamine-β-hydroxylase activity 
and can convert glutamate to GABA. It will also form tumors in nude mice in 
around 3–4 weeks. The loss of neuronal characteristics has been described with 
increasing passage numbers. Therefore it is recommended not to be used after 
passage 20 or verify specific characteristics such as noradrenalin uptake or 
neuronal tumor markers.  
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2.2 Outline and objectives 
Organ printing as promising direction of tissue engineering tends to 
fabricate precisely designed with controlled shape and composition 3D tissue, 
which after a short maturation process would be capable of performing its main 
function and be ready for implantation. To reach this goal the process of tissue 
fabrication has to be evaluated in detailes from different aspects, fabrication 
methods, materials selection, at last, cells viability and functionality.  
In general all tissue/organ fabrication methods are multistep and 
complex, thus they might affect cells viability and functionality during the 
fabrication process. There were developed and studied variety of methods for 
tissue fabrication, with detailed and precise research in materials or methods, 
but not that much attention was paid to cell molecular mechanisms stability 
after encapsulation process, and culturing in artificial 3D environment.  
Thus, the overall objective of the presented work was evaluation of the 
effect of organ fabrication methods on cell parameters, such as viability, activity, 
proliferation and ability to maintain homeostasis in artificial 3D environment.  
The main objective was reached with following aims.  
Chapter 3 – AIM1  
To evaluate the effect of EHDJ encapsulation system on cells behavior.  
Cells were encapsulated in alginate beads by EHDJ method and cultured up to 4 
weeks to evaluate the short- and long-terms effect on cell parameters. At 
defined time points cells encapsulated in the beads were analyzed on their main 
characteristics. It was shown, that cells are mildly stressed first week after 
encapsulation, however towards the 4th week of culturing in the beads, cells 
completely recover of stess, moreover they start to proliferate and adapt the 
alginate bead environment to their own microenvironment, beneficial for their 
growth and functionality.  
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Chapter 4 – AIM 2  
To evaluate the most favorable encapsulation time for variety of applications.   
Cells were encapsulated in alginate microbeads by EHDJ method and cultured 
up to 4 weeks, at the established time points, cells were released from the beads 
and reseeded in tissue culture plates for following experiments. This work is 
targeted for the last step of organ fabrication, maturation. At this stage, cells 
have to replace the material used for fabrication and be able to produce ECM 
and maintain 3D structure without an artificial matrix. Results showed that 
most suitable for tissue maturation is to keep cells in the beads for 21-28 days 
to achieve the highest rate of their functionality in organ printing application. 
For drug screening application though, it was suggested to use cells that were 
encapsulated for 7-21 days.  
 
Chapter 5 - AIM 3 
Fabrication of building units with photolithographic encapsulation system, 
evaluation of cells parameters, and following assembly of fabricated building 
blocks into 3D complex structures.  
For this part, cells were encapsulated in GelMA/PEG hydrogels or seeded on top 
of the beads and analysed for viability and activity. Building blocks were 
assembled by magnetical levitation into 3D structures in a contactless manner 
with high efficiency in short time. Presented results show an easy and fast 
method for fabrication of controlled multishape building blocks and their 
efficient assembly into more complex structures.  
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Chapter 3  
Assessing the impact of electro hydro-dynamic 
jetting on encapsulated cells viability, 
proliferation and ability to self-assemble in 3D 
structures.  
The main part of the presented in this chapter work was published in Tissue 
Engineering: Part C journal.  
Liaudanskaya V., Gasperini L., Maniglio D., Motta A., Migliaresi C. Assessing the 
impact of electro hydro-dynamic jetting on encapsulated cells viability, 
proliferation and ability to self-assemble in 3D structures. Tissue Engineering: 
Part C (2014). 
 
3.1 Abstract 
In this chapter, systemic approach is propose to investigate the impact of 
electrohydrodynamic jetting (EHDJ) encapsulation on viability, proliferation, 
and functionality of the encapsulated cells. EHDJ consists in applying a high-
voltage electrical field between a target substrate and a jetting needle, which is 
fed with a suspension of cells in a polymeric solution undergoing a sol-gel 
transition upon contact with the target. The viability, proliferation, and self-
assembling ability of SHSY5Y human neuroblastoma cell line encapsulated in 
2% alginate microbeads were analyzed by confocal microscopy and DNA 
quantification assays. In addition, the expression of stress (HSP70B’), apoptotic 
(CASP3), necrotic (HMGB1), hypoxic (HYOU1, GAPDH), adhesion (NCDH) and 
extracellular matrix (COL1A1) markers was measured with RT-qPCR. After an 
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initial upregulation of the HSP70B’ expression within 24 h, its expression 
decreased to the negative control level together with a decrease in the 
expression of CASP3. Any increase in necrotic or hypoxic marker expression was 
not detected, while a slight upregulation of NCDH was observed in the first days 
after encapsulation, followed by its downregulation and stabilization to the 
control level. Furthermore, cell-laden beads started to self-assemble in three-
dimensional (3D) constructs from the 3rd week after encapsulation. The results 
indicated that the EHDJ encapsulation method had a mild effect on cells, which 
after a week, fully recovered their proliferation rate and ability to self-assemble 
into 3D constructs.    
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3.2 Introduction 
Cell encapsulation methods consist in the entrapment of cells in 
microcapsules or microbeads starting from a suspension of cells in polymeric 
solution that can be solidified by chemical or physical methods [64]. The 
technology has already found several applications, such as for the long-term 
encapsulation of insulin-producing cells for the diabetes treatment [82], 
chondrocytes phenotype retention [138], stem cells research [32]. Recently, cell 
encapsulation has been investigated for neural regeneration and for the 
treatment of the central nervous system malignancies [139, 140].  
In regenerative medicine, cell encapsulation has received attention for 
the reconstruction of tissues or organs, following an early work of Mironov [29] 
who introduced the concept of organ printing. The procedure consists in the 
layer-by-layer deposition of encapsulated cells that are assembled in 3D 
structures [37, 38] to reproduce the organ/tissue architecture. 3D cell-laden 
structures may also be a suitable model for the fundamental science, drugs 
screening, as well as platform for diseases diagnostics [29, 37, 38, 39, 40]. 
Many methods have been proposed for cell encapsulation, such as 
microfluidics, emulsion, stereo/photolitography and extrusion [64]. These 
methods require a fine tuning of several parameters and an accurate selection of 
the encapsulating materials to keep cells alive, active, and capable of carrying 
out their main functions, such as the ability to self-assemble [44] or to produce 
biomolecules [141]. In the previous years, cell encapsulation has been proposed 
for applications in different fields, like bioprinting or skeletal tissue engineering. 
Agarose, gelatin, chitosan, collagen, polyethylene glycol, hyaluronic acid, 
alginate and other materials have been considered for the encapsulation of cells 
[31, 83-84].  
Viability/activity of encapsulated cells has been already investigated [64, 
85, 142, 143]. Examples are the evaluation of the heat shock protein 60/70 
47 
 
expression in bovine aortic endothelial cells (BAEC) printed by laser pulses 
[64]; the analysis of gene expression on some house-keeping, non- and blood-
specific genes in bio-electrospraying assay of whole human blood [143]; the 
determination of the immune response on the presence of 
allogeneic/xenogeneic hepatoma cells encapsulated in the beads and 
transplanted in rats [85].  
One still open issue is whether encapsulated cells keep their original 
functionality, gene expression profile and ability to self-organize in 
tissues/organs. 
In this study cells were encapsulated in alginate by electrohydrodynamic 
jetting (EHDJ) technology [64, 141, 144]. 
Alginate is a natural polymer derived from the cell wall of brown algae, 
that quick crosslinkings upon contact with calcium containing solutions and can 
dissolve in vivo due to the calcium substitution [82, 83]. Behavioral parameters 
of SHSY5Y neuroblastoma cell line, selected as a model, encapsulated by EHDJ in 
alginate microbeads were assessed in the short-term from 3 hours up to 7 days, 
and in the long-term up to 4 weeks. Cell viability, activity and proliferation, as 
well as ability of cells to self-assemble, and gene expression of stress state-
related markers (CASP3, HMGB1, HYOU1 and HSP70B’) were evaluated in this 
study. Up-regulation of CASP3 (caspase-3) gene–late apoptosis executor, 
indicates the induction of apoptosis in cells [145, 146, 147, 148]; HMGB1 (high 
mobility group box protein 1) is a marker that is specifically produced in 
necrotic conditions [145, 149, 150, 151, 152, 153]; HYOU1 (HYpOxia-Up-
regulated 1) is a hypoxia inducible gene [154, 155, 156, 157], and the house-
keeping gene GAPDH (GlycerAldehyde-3- Phosphate DeHydrogenase) is also 
overexpressed in hypoxic conditions [158, 159, 160]. HSP70B’ (Heat Shock 
Protein 70B’) is specifically produced by cells in stress conditions [161, 162, 
163]. Cell adhesion, motion and communication were evaluated by CDH2 (N-
CaDHerin) expression [164, 165, 166, 167]. Finally, the ability to produce 
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extacellular matrix was analysed with COL1A1 (COLlagen 1A1) expression [168, 
169, 170]. The expression of all above genes in the samples were compared to 
the negative control (cells grown in tissue culture plate (TCP) till 85-90% 
confluence) and to the positive control (with induced hypoxia, apoptosis, 
necrosis and heat shock) [171, 172, 173, 174]. Gene expression level was 
normalized to the house-keeping control gene RPS18 (40S ribosomal protein 
S18) expression [175].  
This paper, therefore, presents a systemic investigation of the influence 
of electrohydrodynamic jetting (EHDJ) encapsulation on cells, with reference to 
the duration of encapsulation and cell viability, their ability to self-assemble, 
proliferate, and the expression of stress-related and some other vitally 
important genes. 
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3.3 Materials and methods  
Materials 
Alginic acid sodium salt from brown algae (alginate) and calcium 
chloride dehydrate were purchased from Sigma-Aldrich (USA). Calcein-AM, 
Propidium Iodide (PI), Phosphate buffer saline without calcium and magnesium 
(PBS), Dulbecco’s modified eagle medium (DMEM) were purchased from 
Invitrogen (USA). The encapsulation system consists of a generator (ES30, 
Gamma High Voltage Research Inc., USA), a pump (NE-300, New Era Pump 
Systems, USA), a polyetrafluorethylene tube and a gauge 33 stainless steal 
needle (outer diameter: 0.210 mm, inner diameter: 0.108 mm Hamilton, 
Bonaduz/Switzerland). SHSY5Y human neuroblastoma cell line (ATCC® CRL-
2266™, UK), Sonicator (UP400S Heilscher, Germany), Quant-iT PicoGreen dsDNA 
Assay Kit (Invitrogen, catalog number: P11496), 0.05% Triton-X 100 in PBS, 
RNeasy Plus Mini Kit (QIAGEN, catalog number: 74134) have been used. 
 
Encapsulation process 
Hydrogel preparation and sterilization.  
Alginate powder was dissolved in PBS for 8 hours at room temperature 
under mild stirring to obtain an alginate solution at the desired concentration 
(2%, 2g/100 ml). Under a biological sterile hood, a syringe filled with solution 
was connected to a pump to be filtered overnight through a 0.22 µm filter. The 
sterile solution was immediately used after filtration. The crosslinking solution 
consisted of calcium chloride dehydrate dissolved in distilled water at a 
concentration of 400 mM, filtered through a 0.22 µm filter under sterile 
conditions.  
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Cell culture.  
SHSY5Y human neuroblastoma cell line was expanded in 25-175mm 
tissue-treated culture flasks as monolayer (passages 12-
of CO2 in high glucose Dulbecco’s Modified Eagle Medium (DMEM) with 10% 
fetal bovine serum (GIBCO), 2mM Glutamine and 1% penicillin-streptomycin 
mixture (Sigma, USA). DMEM medium was changed every third day. The cells 
were cultured to 90-95% confluence before encapsulation [176]. 
 
Preparation of the alginate suspension with cells.  
At 90-95% confluence cells were detached and moved to a 15 ml vial. 
Cells inside the vial were stirred at 1000 rounds/min for 10 minutes and the 
surnatant was removed. Cells on the bottom of the vial were resuspended in 
PBS and stirred again to remove any residues of medium containing cations that 
could crosslink the alginate solution. Cells were dispersed by vibration inside 
the buffer and an aliquot of the solution was taken to count the number of cells 
using a Cellometer Auto T4 (Nexcelom, USA) and Trypan Blue 0,4% (Life 
technologies, USA) as contrast agent. Cells were stirred again, and after 
removing the surnatant the alginate solution was added to obtain an alginate 
suspension containing 5 millions cells for milliliter. Medium, PBS, 
Trypsin/EDTA and the alginate suspension used were warmed to 37°C. 
 
Cell encapsulation by electrohydrodynamic jet method.  
Cell encapsulation was performed by following a protocol already 
published [60]. In brief, the encapsulation system was placed under the 
biological hood, a sterile 3 ml syringe was filled with cells suspended in the 
alginate solution, connected to the polytetrafluoroethylene tube and placed onto 
the pump. The pump was set at the fixed flux of 0.05 ml/min. The other side of 
the tube was connected to the stainless steel needle. The electrical potential was 
established by connecting the positive cathode of the generator to the needle, 
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and the anode to the metallic plate under the Petri dish. The Petri dish 
containing sterile calcium chloride solution was placed below the needle at a 
distance of 5 cm. Once the flux of solution was established and the generator 
was switched on (V=8kV), droplets of alginate solution containing cells were 
ejected from the needle directly to CaCl2 solution. After 10 minutes the beads 
were washed three times with DMEM and redistributed in 6-well tissue culture 
plates to perform the experiment.   
 
Cell release.  
To perform part of in vitro evaluations accordingly to the time points of 
the experiment, cells were first released from the beads. The hydrogel was 
dissolved by removing the DMEM media containing Ca2+ cations with a short 
wash in PBS at room temperature, followed by a 15 minutes incubation in PBS 
at 37°C to favor the ion exchange with the surrounding buffer. After that, the 
samples were centrifuged and cells were collected for the experiment.  
 
In vitro evaluation 
Cell viability.  
Cell viability was estimated by fluorescence visualization (confocal 
microscopy) of samples stained with calcein/propidium iodide. Samples were 
observed 3 hours, 1, 3, 7, 14, 21 and 28 days after encapsulation following 
standard protocols. In brief, samples were incubated for 20 min at 37°C in a 
solution of calcein (1 µl of stock solution for 1 ml of DMEM). After that the 
supernatant was removed, the beads were washed with a CaCl2 solution and 
collected from the bottom of the vial after centrifugation (500 rpm for 1 min). 
The procedure was repeated again at room temperature for 5 min with a 
solution of propidium iodide (100 µl for 1 ml of CaCl2). To validate the results a 
positive control was prepared by inducing the cell death with a 5% H2O2 
treatment overnight.  
52 
 
Cell proliferation.  
DNA extraction was performed by placing the cells extracted from the 
beads in a solution of 0.05% Triton-X in PBS, followed by sonication for 10” 
(cycle: 1, amplitude 40%). After that, DNA was extracted and PicoGreen was 
used for the quantification. Fluorescence intensity of PicoGreen – DNA complex 
was measured in 96-well plates on a plate reader (485 nm excitation and 538 
nm emission; Safire, Tecan, Austria). A calibration curve was built up using the 
DNA standard provided with the assay to correlate fluorescence intensity to the 
concentration of DNA. 
 
Gene expression. 
 Gene expression analysis was performed using quantitative reverse 
transcription polymerase chain reaction (RT-qPCR). Cells were released from 
the beads and total mRNA extraction (3 replicates for each group) was 
performed according to the protocol for the QIAGEN mRNA extraction kit. 
mRNA was resuspended in a final volume of 30 µl with RNAse-free water and its 
yield was quantified by standard spectrophotometry. Reverse transcription 
using 1 µg of total RNA was performed with SuperScript III Reverse 
Transcriptase (Invitrogen, UK) and oligo-dT primers, according to the 
manufacturer’s protocol, in a 20 µl volume. Transcribed cDNA was diluted 1 to 
20 times till a final volume of 100 µl in RNA-free water was obtained. Primers 
were selected from online primers bank PrimerBank [177]. GAPDH primers 
were designed (Table 3.1). Reactions were set up in 10 µl volumes, which 
included 2 µl cDNA, 0.2 µl of each primer, 5 µl of KAPA and 2,6 µl of RNA-free 
water. Amplification and detection was carried out using a CFX96 Touch™ Real-
time PCR machine (BioRad, UK), using the default universal cycling conditions 
recommended by the manufacturer. Measurements were performed in triplicate 
for statistical analysis.  
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RPS 18_f 5'-ATCACCATTATGCAGAATCCACG-3' 
RPS 18_r 5'-GACCTGGCTGTATTTTCCATCC-3' 
GAPDH_f 5’-TCGGAGTGAACGGATTTC-3’ 
GAPDH_r 5’-GCCAGAGTTAAAAGCAGCCCT-3’ 
CASP3_f 5'-GAAATTGTGGAATTGATGCGTGA-3' 
CASP3_r 5'-CTACAACGATCCCCTCTGAAAAA-3' 
HMGB1_f 5'-TATGGCAAAAGCGGACAAGG-3' 
HMGB1_r 5'-CTTCGCAACATCACCAATGGA-3' 
HYOU1_f 5'-GAGGAGGCGAGTCTGTTGG-3' 
HYOU1_r 5'-GCACTCCAGGTTTGACAATGG-3' 
HSP70B’_f 5'-GATGTGTCGGTTCTCTCCATTG-3' 
HSP70B’_r 5'-CTTCCATGAAGTGGTTCACGA-3' 
NCDH_f 5'-AGCCAACCTTAACTGAGGAGT-3' 
NCDH_r 5'-GGCAAGTTGATTGGAGGGATG-3' 
COL1A1_f 5'-CCACCAATCACCTGCGTACAGAA-3' 
COL1A1_r 5'-GGGCAGTTCTTGGTCTCGTCAC-3' 
 
Table 3.1: Primers sequence for RT-qPCR [177].  
 
Statistical analysis 
All statistical analysis was performed with GraphPad Prism 6 software. 
Statistical analysis for more than two groups was carried out using one-way 
ANOVA with Tukey’s post-hoc tests. P<0.05 was considered significantly 
different. Gene expression of SHSY5Y line in tissue culture plate (at passage 16) 
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was set up as a control, and equal to 1. For gene expression analysis the ddCT 
approach was applied [166]. Targeted gene expression was calculated by the 
fold change related to the control group.  
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3.4 Results 
The study was performed up to 4 weeks at different time points: 3 hours, 
1, 3, 5, 7, 14, 21 and 28 days.  During that time cells self-assembly, viability, 
proliferation and gene expression were investigated. 
 
Cell encapsulation 
The parameters for the encapsulation process and beads characteristics 
were already investigated and published [60]. Beads with diameter of about 200 
µm, were made using 2% alginate with 8kV and a G33 stainless steel needle 
(I.D.:0.108 mm) (Figure 3.1A).  
 
Cells self-assembling and migration 
 
Figure 3.1: Beads with diameter consistently stable, about 200 µm were 
made using 2% alginate ejected under 8kV from G33 stainless steel needle (I.D.: 
0.108 mm) to CaCl2 solution for crosslinking. (A) Optical microscope images 
represent cell behavior inside the beads at different time points: 3 hours, 7, 14, 
21 and 28 days after encapsulation. Scale bar is 100µm. (B) Phenotypic 
transition in cells encapsulated in the beads and migrated outside.  
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Cell the morphology, organization and distribution of cells inside the 
beads starting from 3 hours after encapsulation up to 4 weeks presented in the 
Figure 3.1A (Zeiss optical microscope). In the first week cells were small, round-
shaped and homogeneously distributed at the center of beads without visual 
changes up to the 7th day. Toward the 14th day, cells started to proliferate and 
move to the border of the beads. After 2 weeks cells partially moved outside the 
beads, adhering to their surface as well as to the tissue culture plate. Toward the 
28th day after encapsulation, most of the beads were gathered in groups and 
overpopulated by cells. The beads were distorted and partially degraded in 
many cases. Cells that were migrated and attached the TCP surface, made 
clusters with fibroblast-like phenotype from the center to outside (Figure 3.1B). 
 
Cell viability  
Calcein/propidium iodide staining and following fluorescence 
visualization (Confocal microscopy) were used for the cell viability evaluation. 
Images showed homogeneous distribution of the cells encapsulated in the 
beads. Absence of dead cells was observed 3 hours after encapsulation, and few 
1-3 days after (Figure 3.2A). Some dead cells were observed at days 5 and 7. 
During the following 2 weeks few beads with only dead cells were observed, but 
in general there were few dead cells in the beads. At the end, at 28th day no dead 
cells were detected. Results were compared with to the positive control samples 
(necrotic cells).  
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Figure 3.2: (A) Live/Dead analysis with confocal microscopy of SHSY5Y 
cells encapsulated by EHDJ method in 200 µm 2% alginate beads: a) 3 hours; b) 
1; c) 3; d)5; e) 7; f) 14; g) 21; h) 28 days; i) positive control (necrosis induced 
with 4% H2O2 overnight). Scale bar is 100µm.  
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(B) Cell proliferation in the beads analyzed with DNA quantification assay 
within 4 weeks of encapsulation. Circles represent the beads border.  Dead cells 
are evidenced by arrows except than in i). Error bars represent Mean±SD (n=3). 
**p<0.01,  ****p<0.0001. 
 
Cell proliferation 
Cell viability test results were confirmed with followed DNA 
quantification assay. 10% decrease in cell number was detected 24 hours after 
encapsulation (however not statistically significant), and no variations in cell 
number up to the 7th day (Figure 3.2B). After the first week cells number started 
to increase and tripled from the 3rd to the 4th week of encapsulation.  
 
Stress markers expression within the alginate beads 
The results of RT-qPCR have been summarized in Figure 3.3.  
The expression of the targeted genes was compared to cells grown in 
tissue culture plate till 85-90% confluence (culture negative control), and as 
positive control, cells with induced hypoxia, apoptosis, necrosis and heat shock 
were used [171, 172, 173, 174]. One week after encapsulation 20 to 80 times 
increase in HSP70B’ expression was detected, with the highest level after three 
hours (no statistical differences from the positive control) (Figure 3.3A). 
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However, afterward, a stable decrease in HSP70B’ expression was observed 
with complete normalization to the negative control level at day 21 after 
encapsulation. Along with HSP70B’ overexpression, a two fold increase of 
caspase-3 gene (no difference with the positive control sample) was detected in 
the first days after encapsulation, followed by stabilization to the negative 
control level during the next time points, with slight increase again at day 14. 
Necrotic marker HMGB1 expression was detected on the negative control level, 
without statistically different variations during the experimental time points, 
except at day 14 when it was slightly up-regulated and at day 5 when it was 
down-regulated. Both hypoxic markers HYOU1 and GAPDH expression wasn’t 
elevated during the whole encapsulation time. However, HYOU1 expression 
during the first 3 weeks was significantly below the negative control level, 
whereas the GAPDH expression was comparable to the negative control 
samples. In the first 24 hours double up-regulation of N-cadherin expression 
was detected, followed by a significant down-regulation at the next time points, 
stabilization to the control level at days 14 and 21 and by down-regulation again 
at day 28.  
Eventually, collagen1A1 expression was decreasing within 3 days of 
encapsulation, and after the significant increase in the expression was observed 
up to the 14th day, followed by down-regulation till the last experimental time 
point (Figure 3.3E).  
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Figure 3.3: RT-qPCR analysis of stress/apoptotic/necrotic markers in 
SHSY5Y cells encapsulated in 2% alginate beads by EHDJ method and evaluated 
at 8 time points. Expression of all targeted genes in studying samples were 
compared to the negative control samples (cells grown in tissue culture plate) 
and to the positive control samples (with induced hypoxia, apoptosis, necrosis 
and heat shock) [171, 172, 173, 174]. A) Expression level of HSP70B’- stress 
marker; B)CASP3, HMGB1 – apoptotic/necrotic markers; C)HYOU1,GAPDH - 
hypoxia markers; D)CDH2 – adherence marker; E)COL1A1 – extracellular matrix 
marker. Error bars represent Mean±SD (n=3). *p<0.05, **p<0.01, ***p<0.001, 
****p<0.0001.  
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3.5 Discussion 
Methods of cell encapsulation are complex and can damage cells, change 
their ability to self-assemble or other vital characteristics. A deep and systemic 
analysis is essential to control cells functionality and activity after processing.  
 In particular, referring to EHDJ encapsulation, heat, oxygen or nutrition 
deficiency, shear stress, as well as high electrical fields can lead to changes in 
cell behavior, such as decreased proliferation rate and activity, inability of cells 
to communicate and self-organize, changes in cell molecular mechanisms 
(cancer metastasis, or autophagy), or to stress accumulation. Eventually, as a 
consequence of stress exposure, cell death can be triggered by two different 
mechanisms: apoptosis or necrosis (Figure 3.3) [158, 178, 179]. Generally 
necrosis is the result of severe trauma or injury, whereas apoptosis, or 
programmed cell death, happens as the result of normal cell cycle, or it can be 
enhanced by some mild outer stimuli, like hypoxia, heat or the presence of some 
molecules [145, 179]. Several methods have been developed for 
apoptosis/necrosis evaluation, based on the microscopic evaluation of 
phenotypic changes, nuclei fragmentation, detection of molecular markers, like 
phosphatidylserine (PS) presence, different caspases and HMGB1 expression or 
cytochrome c release; some of these methods are mentioned in Figure 3.4.  
In this study apoptosis/necrosis detection was performed at the 
molecular level; methods based on microscopic observations after 
immunostaining were not efficient and informative due to the interference of 
the alginate matrix.  
Before or in some cases even after the activation of programmed or acute 
cell death pathways, heat shock proteins (HSP) are produced for protection 
[161, 162, 163, 180, 181]. The HSP family is composed of proteins that are 
increasingly expressed in response to stresses (ex. Hsp70A, Hsp90), with some 
members of the family specifically expressed in particular stress conditions like 
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heat, hypoxia and heavy metals exposure (ex. Hsp60, Hsp70B’, Hsp72) [159, 
160, 161]. In literature there are reports about cell stress resistance due to the 
HSP over-expression and cell recovery [176, 182]. However, HSP over-
expression generally points to the presence of stress with no indications about 
its nature.  In addition to HSP, specific genes like, HIF1α, HYOU1 and GAPDH are 
good markers for hypoxia detection [154, 155, 156, 157, 158, 159, 160, 161, 
162, 183]. Caspase is the major family of proteases that is responsible for 
apoptosis propagation, with specific genes for each stage: caspase 8,9  are early 
markers, whereas caspase 3 and 7 are late apoptotic executors, the expression of 
which can directly point to the propagation of apoptosis [145, 146, 147, 148]. 
HMGB1 over-expression is a good diagnostic marker to detect the presence of 
necrosis.  
 
Figure 3.4: Theoretical model of cell response to stress exposure. In red 
boxes, factors that were evaluated in this article. 
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This study evaluated with a systemic approach the effect of EHDJ 
encapsulation on the cell characteristics like ability to self-assemble, viability, 
activity, proliferation and the expression of specific genes (stress, apoptotic and 
necrotic). In vitro evaluations were performed at different time points to check 
the short-term effect from 3 hours up to 7 days after encapsulation, and long-
term up to 4 weeks. SHSY5Y human neuroblastoma cells at passage 16 were 
encapsulated in 2% alginate beads (200 µm diameter) applying 8kV to the 
extrusion needle. 
Initially, short-term effect (stress molecules production and apoptosis 
propagation) of EHDJ encapsulation on the cell’s behavior was analyzed. RT-
qPCR analysis indicated 3 hours after encapsulation HSP70B’ expression 80 
times higher than in the negative control group (Figure 3.3A). HSP proteins 
main function is to protect cells against apoptosis, necrosis, hypoxia or other 
type of stresses. Stress accumulation leads to HSP family over-expression, that 
in turn, induces cell stress recovering, followed by cell stress resistance [176, 
180, 181, 182, 184]. However, notwithstanding the expression of HSPs, under 
severe stress conditions cells can overpass the function of HSP and initiate 
programmed cell death propagation [176]. Cell viability analysis showed 
absence of cell death 3 hours after encapsulation, however investigation at the 
1st and the 3rd day revealed the presence of some dead cells (Figure 3.2A). Cell 
viability results were confirmed at molecular level by the 2-2.5 fold increase of 
the expression of CASP3 (caspase-3) gene in the first hours after encapsulation 
till the first day (Figure 3.3B). In the following days (3-7), CASP3 expression 
decreased and stabilized to the negative control level, supporting the cell 
viability test. In fact at day 7 after encapsulation a decreased amount of dead 
cells was observed. Our experimental results agree with the results found in 
literature about the molecular mechanisms of cell stress protection and 
apoptosis propagation in stress conditions [176]. Cell death reaches the 
maximum level 24 hours after stress exposure following the caspase-3 cleavage 
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and activation [185]. DNA quantification test confirmed the results above and 
showed 10% decrease in cell number the first day after encapsulation (not 
significantly different) (Figure 3.2B). Up to the 7th day of the experiment there 
wasn’t any significant variations in cell number. These results prove that the 
EHDJ encapsulation system has mild stress effect on the cells in first 24 hours, 
however they are able to recover in a short time and remains viable.  
Long-term encapsulation can cause nutrition or oxygen deficiency that in 
turn can trigger stress accumulation and apoptosis propagation, as well as 
hypoxia followed by necrotic cell death. From the 5th day of the encapsulation, 
the level of HSP70B’ increased again up to 50 times. However, after the 7th day 
HSP70B’ expression declined in a clear trend with full recovery to the negative 
control level at day 21. At day 14, together with a slightly elevated HSP70B’ 
expression, death-related markers level was also elevated. The cell viability test 
showed a moderate amount of dead cells (Figures 3.2A). Expression of hypoxic 
markers HYOU1 and GAPDH was comparable to the negative control at later 
time points (Figure 3.3B,C). Up to the 4th week of encapsulation the expression 
of stress-related markers wasn’t observed. Along with a decline in the 
expression of HSP70B’, cells regain their ability to proliferate and the results of 
DNA quantification test showed two fold increase in cell number between the 
first week and the second, and triplication towards the 4th week. Presumably, 
the initial HSP70B’ overexpression led cells to the stress resistant state, 
protecting them against hypoxia or other impulses. This is supported by 
literature and the analysis about stress resistance development after HSP family 
overexpression in stress conditions [161, 162, 163]. Peculiarly, significant 
decrease was detected in HMGB1 and CASP3 expression at day 5, compared to 
the negative control. This can be explained by the absence of the physiological 
1-5% cell death because of the lack of cell proliferation [145, 146, 147, 148]. A 
decreased level of HYOU1 was observed at days 3 and 7. To understand whether 
HSP70B’ overexpression has a real protective effect on the encapsulated cells, 
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further experiments with HSP70B’ silencing need to be conducted. Obtained 
results suggest an absence of stress conditions and stable cell state inside the 
beads during the 3 weeks followed by the first week of stress recovering after 
encapsulation process.  
At last, the cells ability to adapt in artificial environment was evaluated 
with two markers: N-cadherin and collagen1a1 [164, 165, 166, 167, 168, 169, 
170]. Double up-regulation of N-cadherin observed during the first days of the 
experiment can be the result of cells growing inside the beads. These results 
suggest cells released 24 hours after encapsulation will have favorable 
conditions for adhesion and self-assembly, in fact, this phenomenon was 
described in the literature earlier [185, 186]. However, considering that SHSY5Y 
cells used in the experiment are tumor cell line, there can be another 
explanation for this phenomenon. According to the literature review, 
overexpression of N-cadherin leads to metastatic cells flow and to increased 
level of trans-endothelial migration [167]. However, the chemistry of the 
material can lead to decrease in the ability of cells to adhere. This was observed 
from double down-regulation of N-cadherin expression toward the 7th day of 
encapsulation. During the following weeks N-cadherin expression was varied, 
but within the control level. The initial decrease in the collagen1A1 expression 
can be explained by the cell stress recovery up to the third day after 
encapsulation [168, 169, 170]. After cells recovered of stress the level of 
collagen1A1 was increased within 2 weeks, followed by its downregulation. The 
expression pattern can be easily explained and compared with other cell 
parameters, the initial low level was the result of stress recovery, after that cells 
started modification of the alginate bead environment to their functional niche. 
Within 2 weeks cells produced sufficient amount of extracellular matrix, thus 
the expression of collagen1a1 wasn’t necessary and its downregulated. By the 
time niche was modified cells started active proliferation and assembly (Figure 
3.1A, 3.2B).  
67 
 
After 2 weeks cells started massive migration outside the beads, followed 
by its attached to the surface of the alginate beads and the tissue culture plate. 
Alginate lacks adhesion motifs and as a consequence, cell adhesion to its surface 
was weak. Even though beads were gathered in clusters overgrown by cells, 
they were not firmly adherent and could be detached applying shaking or 
pipetting. However, for organ printing application this technique can be applied 
in a very efficient way, where cells could be printed in very precise 3D structure 
on the top, or inside of different matrices, what will support cell migration and 
self-assembly even better.  
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3.6 Conclusions 
In summary, SHSY5Y cells encapsulated by EHDJ method in 200µm 2% 
alginate beads are subject to mild stress conditions, whereby they are able to 
recover in a short time. In fact, our analysis showed that cells could be 
encapsulated up to 4 weeks without undergoing cell death or oxygen deficiency. 
Cells kept their ability to self-assemble in 3D constructs mimicking an in vivo 
morphogenesis. This is a positive phenomenon for tissue maturation in organ 
printing application.  
This article provides a systemic approach for the evaluation of the effect 
of EHDJ encapsulation on cell behavior in short and long term (up to 4 weeks 
after encapsulation).  In this study, we proposed a protocol for evaluation of the 
EHDJ encapsulation effect on the cell behavior. This protocol can be used not 
only for the EHDJ encapsulation method but also for other tissue engineering 
methods. To obtain a full picture of the effects of EHDJ encapsulation, further 
experiments are needed to evaluate tissue/organ maturation in post-
encapsulation time [29, 37, 140].  
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Chapter 4 
Homeostasis maintenance is critical parameter 
for application of cell encapsulation in tissue 
fabrication.  
4.1 Abstract  
Cell niche homeostasis plays a critical role in many body functions, such 
as tissue functionality, stem cell maintenance and differentiation, wound 
healing, cancer development and propagation, and many others. Thus, it’s a 
crucial parameter to control in tissue fabrication process, application of 
knowledge about cell homeostasis and microenvironment can drastically 
improve tissue maturation and following post-transplantation adaptation. The 
main goal of this study was to evaluate post-encapsulation behavior of cells 
referring to their ability to maintain homeostasis and functionality such as 
viability with apoptosis-necrosis rate analysis, activity with Alamar Blue test, 
proliferation with DNA quantification assay, and ability to form niche with N-
cadherin expression. The results were collected for 8 experimental groups: cells 
encapsulated in the beads for different time from 3 hours up to 4 weeks and 
compared to the control group. It was suggested based on the observed results 
that optimal time for beads maturation and niche formation is 4 weeks. Cells 
self-assembly into tight micro-clusters with high level of N-cadherin expression, 
high activity and proliferation potential, so as relatively low cell death level 
would be beneficial for tissue adaptation post-implantation.  
Moreover, there was suggested a variety of applications for EHDJ 
produced beads, besides tissue fabrication for transplantation, such as 3D 
models for diseases molecular mechanisms understanding, cosmetics testing 
70 
 
and drug screening. Thus, it was proved that EHDJ encapsulation system is safe, 
easy in manipulation, and suitable for application in different fields.  
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4.2 Introduction  
The idea of the body’s ability to achieve an internal balance in the 
changing environments was first mentioned around 200 years ago, in 1920 by 
Walter Cannon this process was termed homeostasis [188].  Cell homeostasis is 
the capability of biological systems to maintain a relatively stable milieu in a 
fluctuating external environment [189]. Evolutionary cells of many organisms, 
including humans have learned how to survive and function even in extreme 
conditions, all because of cells adaptation and homeostasis maintenance. Cell 
niche homeostasis plays a critical role in many body functions, such as stem cell 
maintenance and differentiation, temperature balance, in cancer development 
and propagation, and many others [189, 190, 191, 192, 193, 194]. “Niche” or cell 
microenvironment according to Scadden’s definition is specific anatomic 
location that regulates how cells participate in tissue generation, maintenance 
and repair. Cell niche or microenvironment is in the majority extracellular 
matrix, it can contain as well blood vessels, nerves or any other factors that 
would maintain cells viability, differentiation and functionality [192, 193, 194]. 
Thus, extracellular matrix (ECM) is the main component of the cellular niche 
and composed of proteins with supporting function, such as collagens, laminins, 
elastins and others; biomolecules, with nutrition and fate-controlling function, 
such as growth factors, small integrin-binding glycoproteins; at last 
proteoglycans, and water [93, 94, 95, 96]. ECM always undergoes slight 
modifications by cells activity. ECM plays a key role in cell activity like 
proliferation, adhesion, migration, differentiation, apoptosis and gene 
expression [94].  
The general goal of regenerative medicine is focused on recovering, 
restoration or replacement of damaged or diseased tissues with in vitro 
fabrication of proper substitution [195, 196, 197, 198]. Application of 
knowledge about tissue homeostasis and cell microenvironment into tissue 
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fabrication process can drastically improve tissue maturation and following 
post-transplantation adaptation [196, 199]. One of the most commonly used 
technologies for tissue fabrication is organ printing, which is relatively new 
direction however it already received a profound attention as promising 
technique. Organ printing composed of three main steps according to prof. 
Mironov, the first step calls pre-processing, which is the tissue/organ design 
using computer tomography scanning or any other similar technologies to 
define precise tissue composition [29]. The next step is processing or direct cell 
encapsulation. Cell encapsulation techniques are widely used in tissue 
engineering as simple yet powerful tool for tissue fabrication [49, 50, 51, 52, 
83]. At last, post-processing, or organ maturation, which is mainly focused on 
cells expansion inside the matrix and maintaining 3D tissue substitutes in 
bioreactors that would mimic in vivo microenvironments [27, 28, 29, 30]. The 
last step of organ printing, post-encapsulation is the most critical and important 
for tissue homeostasis maintenance. In many cases cell encapsulation process 
implies stem cells, because of its multi or pluripotency potential, what makes 
post-encapsulation maintenance is crucial for proper stem cells differentiation 
and self-renewal.  
At present, many techniques and protocols were developed and applied 
for cell encapsulation, such as photolithography, microfluidic encapsulation, 
ink-jet and bioprinting [49-81], so as many materials were evaluated for above-
mentioned applications [16, 17, 18, 19, 20, 21, 82, 84, 87, 88, 89, 90, 91, 92]. 
However, some work was already done [22, 42, 85, 143], on cell parameters 
evaluation during or post encapsulation, but still many aspects need to be 
addressed. Cell homeostasis and microenvironment maintenance post-
encapsulation are critical parameters to control for successful tissue fabrication.  
In recently published study a detailed analysis of cell viability, metabolic 
activity and cell stress level was made on cells encapsulated in the alginate 
beads by EHDJ encapsulation [22]. Study showed cells were subjected to a mild 
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stress, however they were capable to recover in short time, and maintain their 
main functions, like proliferation and ECM production.   
Moreover, this study showed cells within 3 weeks modified artificial 
alginate environment into their functional niche, by producing ECM 
components, like collagen1 and N-cadherin. However, the main goal of 
maturation process, the third step of organ printing, is formation of 
homeostatically stable, functional tissue, where artificial matrix used initially for 
tissue fabrication process, would be substituted by the cells ECM, including 
growth factors, and biomolecules important for proper tissue function [29, 30, 
93]. Thus, maturation process can be considered as completed, when fabricated 
tissue can maintain its structure and stability by itself without external factors 
and support. 
The main goal of this study was to evaluate post-encapsulation behavior 
of cells referring to their ability to maintain homeostasis and functionality such 
as viability: apoptosis-necrosis rate, activity and proliferation. 
Thus, to be able fully evaluate cells state and capacity to maintain 
fabricated tissue structure they were placed in control conditions (TCP), and 
supplied with full media after being encapsulated up to 4 weeks. Without an 
artificial matrix (which has to degrade in fabricated tissue) cells were tested for 
their ability to maintain homeostasis and self-assembly ability, and some 
functionality parameters like cell death rate, proliferation and activity level. 
SHSY5Y human neuroblastoma cell line (neural progenitors) was used as a 
suitable model for encapsulation [200]. Cells at passages 12-16 were 
encapsulated by EHDJ encapsulation method in 2% alginate beads (beads size 
varied around 200m) up to 4 weeks [22, 60]. Cells were released from the 
beads by dissolving the alginate in PBS and reseeded in TCP after they were 
washed with media to remove alginate residues at 8 time points: 3 hours, 1 day, 
3, 5, 7, 14, 21 and 28 days after the encapsulation. Cells seeded in TCP without 
being encapsulated before were used as a control group. After reseeding cells 
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were subjected to a set of in vitro tests for evaluation of viability with 
apoptotic/necrotic detection kit, metabolic activity with Alamar blue assay, 
proliferation level with DNA quantification assay, at last adhesion, motion and 
cell-cell communication properties with N-cadherin expression at 4 time points: 
day 1, 3, 5 and 7.  
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4.3 Materials and methods  
Materials 
Alginic acid sodium salt from brown algae and calcium chloride 
dehydrate were purchased from Sigma-Aldrich (USA). Phosphate buffer saline 
without calcium and magnesium (PBS), Dulbecco’s modified eagle medium 
(DMEM) were purchased from Invitrogen (USA). The encapsulation system 
consists of a generator (ES30, Gamma High Voltage Research Inc., USA), a pump 
(NE-300, New Era Pump Systems, USA), a polyetrafluorethylene tube and a 
gauge 33 stainless steal needle (outer diameter: 0.210 mm, inner diameter: 
0.108 mm Hamilton, Bonaduz/Switzerland). SHSY5Y human neuroblastoma cell 
line (ATCC® CRL-2266™, UK), Sonicator (UP400S Heilscher, Germany), Quant-iT 
PicoGreen dsDNA Assay Kit (Invitrogen, catalog number: P11496), 
Apoptotic/Necrotic kit (PromoKin PK-CA707-30017); 0.05% Triton-X 100 in 
PBS; paraformaldehyde (PFA) 4%; antibody for N-cadherin (santa cruz rabbit 
sc-7939), DAPI (life technologies).  
 
Encapsulation process.  
Hydrogel preparation and sterilization.  
Alginate powder was dissolved in PBS for 8 hours at room temperature 
under mild stirring to obtain an alginate solution at the desired concentration 
(2%, 2g/100 ml). Under a biological sterile hood, a syringe filled with solution 
was connected to a pump to be filtered overnight through a 0.22 µm filter. The 
sterile solution was immediately used after filtration. The crosslinking solution 
consisted of calcium chloride dehydrate dissolved in distilled water at a 
concentration of 400 mM, filtered through a 0.22 µm filter under sterile 
conditions. 
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Cell culture. SHSY5Y human neuroblastoma cell line was expanded in 25-
175mm tissue-treated culture flasks as monolayer (passages 12-16) at 37°C 
under 5% of CO2 in high glucose Dulbecco’s Modified Essential Medium (DMEM) 
with 10% fetal bovine serum (GIBCO), 2mM Glutamine and 1% penicillin-
streptomycin mixture (Sigma, USA). DMEM medium was changed every third 
day. The cells were cultured to 90-95% confluence before encapsulation [176]. 
 
Preparation of the alginate suspension with cells.  
At 90-95% confluence cells were detached and moved to a 15 ml vial. 
Cells inside the vial were stirred at 1000 rounds/min for 10 minutes and the 
surnatant was removed. Cells on the bottom of the vial were resuspended in 
PBS and stirred again to remove any residues of medium containing cations that 
could crosslink the alginate solution. Cells were dispersed by vibration inside 
the buffer and an aliquot of the solution was taken to count the number of cells 
using a Cellometer Auto T4 (Nexcelom, USA) and Trypan Blue 0,4% (Life 
technologies, USA) as contrast agent. Cells were stirred again, and after 
removing the surnatant the alginate solution was added to obtain an alginate 
suspension containing 5 millions cells for milliliter. Medium, PBS, 
Trypsin/EDTA and the alginate suspension used were warmed to 37°C. 
 
Cell encapsulation by electrohydrodynamic jet method.  
Cell encapsulation was performed by following a protocol already 
published [60]. In brief, the encapsulation system was placed under the 
biological hood, a sterile 3 ml syringe was filled with cells suspended in the 
alginate solution, connected to the polytetrafluoroethylene tube and placed onto 
the pump. The pump was set at the fixed flux of 0.05 ml/min. The other side of 
the tube was connected to the stainless steel needle. The electrical potential was 
established by connecting the positive cathode of the generator to the needle, 
and the anode to the metallic plate under the Petri dish. The Petri dish 
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containing sterile calcium chloride solution was placed below the needle at a 
distance of 5 cm. Once the flux of solution was established and the generator 
was switched on (V=8kV), droplets of alginate solution containing cells were 
ejected from the needle directly to CaCl2 solution. After 10 minutes the beads 
were washed three times with DMEM and redistributed in 6-well tissue culture 
plates to perform the experiment.   
 
Cell release.  
To reseed cells for in vitro evaluations cells were released from the beads 
and reseeded in 12-well plate tissue culture plates. The hydrogel was dissolved 
by removing the DMEM media containing Ca2+ cations with a short wash in PBS 
at room temperature, followed by 15 minutes incubation in PBS at 37°C to favor 
the ion exchange with the surrounding buffer. After that, the samples were 
centrifuged and cells were collected for counting. Cells were resuspended in 5 
ml of full cell culture media. Cells were dispersed by vortexing inside the media 
and an aliquot of the solution was taken to count the number of cells using a 
Cellometer Auto T4 (Nexcelom, USA) and Trypan Blue 0,4% (Life technologies, 
USA) as contrast agent.  
 
In vitro evaluation 
The study was performed up to 4 weeks on 8 different groups: 3 hours, 1, 
3, 5, 7, 14, 21 and 28 days after encapsulation. The reference group was cells in 
TCP without being encapsulation before. Samples were subjected to a set of 
tests at 4 time points: day 1, 3, 5 and 7. Table 4.1 represents the schematic 
schedule of the conducted experiment. 
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Table 4.1: Scheme of the conducted set of experiments for evaluation of 
cells viability, apoptosis/necrosis rate, activity and adhesion ability post-
encapsulation.  
 
Apoptosis/necrosis evaluation.  
Cell death type was evaluated using PromoKine apoptotic/necrotic kit. 
Briefly, cells were fixed with 4% PFA in the tissue culture plate at established 
time points. Samples were washed twice with 1X Binding buffer, and after were 
incubated for 15 min with solution of 5µl of FITC-Annexin V and of 5µl of 
Ethidium Homodimer III in 100 µl of 1X Binding Buffer (light protected). Next, 
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samples were washed twice with 1X Binding buffer and stained for 5 min with 
DAPI (light protected). After brief washing in PBS results were analysed with 
Nikon confocal microscope. Green light represented apoptotic cells, red color for 
necrotic cells, and blue for the nuclei, corresponding to the total amount of cells. 
The results were obtained in the view of confocal fluorescent images, and the 
total number of cells, apoptotic and necrotic cells were calculated with ImageJ 
cell counter plugin. After results were analysed with GraphPrism 6 software. All 
the samples were made in triplicates, and for each sample there was made 3 
images for statistical calculation. 
 
Cell proliferation.  
DNA extraction was performed by placing the cells extracted from the 
beads in a solution of 0.05% Triton-X in PBS, followed by sonication for 10” 
(cycle: 1, amplitude 40%). After that, DNA was extracted and PicoGreen was 
used for the quantification. Fluorescence intensity of PicoGreen – DNA complex 
was measured in 96-well plates on a plate reader (485 nm excitation and 538 
nm emission; Safire, Tecan, Austria). A calibration curve was built up using the 
DNA standard provided with the assay to correlate fluorescence intensity to the 
concentration of DNA. 
 
Cell activity.  
Cells activity was measured with Alamar Blue assay. Cells were incubated 
with 10% Alamar Blue solution in full DMEM media for 2.5 hours protected 
from light. After incubation, 100 µl of solution of each sample was transferred to 
96-well plate (black) and measured with fluorescent plate reader machine (485 
nm excitation and 538 nm emission; Safire, Tecan, Austria). After samples were 
washed with PBS solution and placed at 37°C in full DMEM media till the next 
time point assay.  
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N-cadherin expression with immunocytochemistry assay.  
Reseeded cells were fixed with PFA 4% for 30 min, after samples were 
blocked and permeabilized with blocking buffer (1% BSA, 0,3 % TritonX in PBS) 
for 1 hour. Primary antibody to N-cadherin (sc-7939) was applied for overnight 
at 4C°. After PBS washing was performed 3 times for 10 minutes. Secondary 
anti-rabbit antibody was applied for 1 hour at room temperature with following 
3 times washing in PBS. At last, DAPI solution was applied for 5 min. After, cells 
were washed twice with PBS. Results were analysed with the confocal 
microscope (Nicon).  
 
Statistical analysis 
All statistical analysis was performed with GraphPad Prism 6 software. 
Statistical analysis for more than two groups was carried out using one-way 
ANOVA with Tukey’s post-hoc tests. P<0.05 was considered significantly 
different. All samples were prepared in triplicates for statistical difference 
validation.   
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4.4 Results 
The results were analyzed within each experimental group at 4 
experimental time points and compared to the reference group and within each 
other. All results presented in Figures 4.1-4.7.  
Control group (1). There was observed a general low level of cell death 
rate, with decreasing level of necrosis from the first towards the last 
experimental time point. Control samples had high proliferation potential so as 
high activity level. Addition to that, control cells show high level of N-cadherin 
experission at all experimental times, and homogeneous cell population with 
epithelial like phenotypes, as it specific for SHSY5Y cell line (Figures 4.1-4.7).  
3 hours group (2). The first experimental group, showed statistically 
similar to the control group results. The general cell death rate was on the same 
level, with slight increase of necrosis on the third day of culturing, similar cell 
number adhered to the tissue culture plates, and proliferated in the same 
pattern as the control group. There was found significant difference in the 
number of cells in suspension at day 7 after reseeding. At last, there was 
observed no differences in the cell phenotypes and grow patterns, so as in the 
level of N-cadherin expresion (Figures 4.1-4.7).  
1 day group (3). Cells reseeded one day after encapsulation, showed 
significant increase in the cell death rate (both apoptotic and necrotic) within 3 
days of culturing, however it gradually decreased towards the 7th day of 
culturing. Cell proliferation level significantly slowed, but reached the control 
level at 7th day of cultring. There was also obsereved an increasing amount of 
cells in suspension, especially the last day of culturing. At last, cell-cell 
communication was disturbed, by decreased amount of N-cadherin expression, 
though phenotypically cells were similar to the control group (Figures 4.1-4.7). 
3, 5 and 7 days groups (4,5 and 6). The next set of experimental groups 
had similar pattern in all the conducted tests. All groups showed an increase in 
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cell death level, but only at the first and the last day of culturing, whereas in the 
middle cell death rate was on the control level. Next, proliferation rate was 
slower than in the control group, but had the same pattern. The 4th group had 
the highest amount of cells in suspension at day 7 after reseeding, and the 
lowest level of N-cadherin expression at this time. Group 5 had significantly 
lower amount of cells in suspension by the 7th day of culturing, and very high 
level of N-cadherin expression. At last, group 6 had the highest level of cells in 
suspension the first day after reseeding, and very low level of N-cadherin 
expression this time point, but amount of cells in suspension reached the 
control level by day 7 of culturing, so as the N-cadherin expression. There was 
also observed phenotypical shift to the mesenchymal-like in the groups 5 and 6 
groups, but the growing pattern was the same as in the control group, 
homogeneous distribution on the surface of tissue culture plate (Figures 4.1-
4.7).  
 
Figure 4.1: Apoptotic/necrotic cell death evaluation. Cells were stained 
with DAPI for detection of the total amount of cells. An example of Promikine kit 
stainings with experimental sample of Day 7.  
14 days group (7). This group of samples had the lowest level of necrosis 
the first day after reseeding, but the highest apoptotic level among all the 
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experimental groups and samples, which completely recovered to the control 
level towards the 7th day of culturing. The total cell number was on relatively 
low level, but higher than in groups 4-6. There was observed very high amount 
of cells in suspension the first day (supports the high amount of apoptotic cells), 
but the amount of cells in suspension returned to the control level at next 
experimental point. The activity of this group was on relatively low level as well. 
There was observed from the first day the highest level of N-cadherin 
expression within all the experimental time. At last, cells had mesenchymal-like 
phenotypes and they started to grow in tigher groups (Figures 4.1-4.7).  
21 days group (8). This group had the highest level of necrotic cell death, 
but it gradually decreased towards the last experimental day. The apoptotic cell 
death level was elevated as well the first day after reseeding, but it completely 
recovered towards the last day of culturing. This group as well had the quite low 
proliferation level, so as cell activity level was quite low, the level of cells in 
suspension was on the control level at all time points. There were also observed 
tight cells cluster with very high level of N-cadherin expression, at last cells had 
mesenchymal-like phenotype (Figures 4.1-4.7).  
28 days group (9). At last, cells reseeded after 28 days in the beads had 
elevated level of cell death at all points, but first day. However, this group of 
cells had the highest proliferation rate, hence the activity level was very high as 
well. There was observed very high amount of cells in suspension first day 
reseeding, so as the last day, even with the highest level of N-cadherin 
expression at all experimental points. At last, cells were growing in very tight 
groups in multi-layers with overexpression of N-cadherin in this areas (Figures 
4.1-4.7).  
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Figure 4.2: Cell death type and rate evaluation with PromoKine in 8 
studying groups and the reference control group. Experimental and reference 
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groups were subjected to apoptosis/necrosis detection at 4 time points: day 1, 
3, 5 and 7. The results were evaluated with confocal microscope, and following 
calculations with ImageJ cell counter plugin. A. Total amount of cell death; B. 
Apoptosis rate; C. Necrosis rate. Statistical analysis was performed comparing 
results of experimental groups to the control one within in vitro evaluation 
days: 1, 3, 5 and 7.  Error bars represent meanSD (n=3). *p<0.05, **p<0.01, 
***p<0.001, and ****p<0.0001 
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Figure 4.3: Cell proliferation rate measured with DNA quantification 
assay. All experimental groups and control were divided in 2 subgroups: cells 
adhered to the surface of tissue culture plate, and cell in suspension that were 
not able to adhere. Experimental and reference groups were subjected to DNA 
quantification test at 4 time points: day 1, 3, 5 and 7. A. Cells adhered to the 
surface of tissue culture plates; B. Cells in suspension.  Statistical analysis was 
performed comparing results of experimental groups to the control one within 
in vitro evaluation days: 1, 3, 5 and 7.  Error bars represent meanSD (n=3). 
*p<0.05, **p<0.01, ***p<0.001, and ****p<0.0001 
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Figure 4.4: Cell activity rate measured with Alamar Blue assay. 
Experimental and reference groups were subjected to Alamar Blue assay at 4 
time points: day 1, 3, 5 and 7. Statistical analysis was performed comparing 
results of experimental groups to the control one within in vitro evaluation 
days: 1, 3, 5 and 7.  Error bars represent meanSD (n=3). *p<0.05, **p<0.01, 
***p<0.001, and ****p<0.0001 
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Figure 4.5: The ability to communicate and self-assemble in groups was 
evaluated with N-cadherin/DAPI expression at Day 1 on cells encapsulated in 
2% alginate beads by EHDJ method, released and reseeded at 8 experimental 
time points in control conditions, and compared to the group of cells that were 
not encapsulated. 
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Figure 4.6: The ability to communicate and self-assemble in groups was 
evaluated with N-cadherin/DAPI expression at Day 7 on cells encapsulated in 
2% alginate beads by EHDJ method, released and reseeded at 8 experimental 
time points in control conditions, and compared to the group of cells that were 
not encapsulated. 
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Figure 4.7: Phenotypic changes and growth patterns were evaluated with 
brightfield imaging of cells encapsulated in 2% alginate beads by EHDJ method, 
released and reseeded at 8 time points in control conditions and compared to 
the group of cells that was not encapsulated.   
91 
 
4.5 Discussion 
 Organ printing is complex multistep technology of tissue, organ 
fabrication. Dr. Anthony Atala recently published a review in Nature on 
bioprinting and the requirements for successful tissue production [27]. One of 
the main requirements is the cell source and its functionality [28, 29, 30]. 
According to this review, cells must have a high proliferation potential and 
activity, especially initially after implantation to reach the proper cell number 
and build the extracellular matrix that would support the tissue structure 
without an artificial matrix. Another key parameter for successful tissue 
fabrication is cell microenvironment maintenance [93, 94]. Control over cell 
microenvironment is crucial aspect for tissue engineering and regenerative 
medicine research [201]. By manipulating cell niche composition it is possible to 
affect cells behavior via biophysical, biochemical or other mechanisms [191, 
192, 193, 194, 197]. Thus, tissue engineering has to combine the knowledge 
about cell microenvironment and surrounding physical forces with engineering 
methods for successful 3D tissue fabrication and its following maturation [199].  
In the previous chapter, there was presented a detailed study of EHDJ 
encapsulation system effect on cells behavioral characteristics, that showed 
high level of cell viability, activity and proliferation potential [22]. After the 
tissue fabrication, maturation follows, thus the next step, was to evaluate the 
best encapsulation time in terms of most favorable cell parameters for tissue 
maturation, such as high proliferation potential, ECM matrix production and low 
death rate.  
Thus, here is presented a deep study of cells behavior post-encapsulation 
by electrohydrodynamic jetting in 2% alginate beads for different time up to 4 
weeks, and discussion over the most suitable cell conditions for successful 
tissue maturation referring to cells ability to maintain homeostasis by adapting 
artificial matrix to their functional niche.    
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The main application of EHDJ encapsulation system is for the second step 
of organ printing. The crucial requirement for this application is the production 
of 3D structures with viable functional cells capable of maintaining their 
homeostasis during the maturation process [27, 28, 29, 30, 31]. Eventually, by 
the time of transplantation cells encapsulated in artificial 3D conditions, have to 
modify surrounding environment to their functional niche by degrading the 
artificial matrix and replacing it with their own ECM and biomolecules 
important for homeostasis maintenance [93, 94, 95, 188-195].  
As it was shown in the previous study [22], cells undergo mild stress 
during and 48 hours after encapsulation, but with elevated level of heat shock 
proteins expression (play a critical role in cells recovery during and after stress) 
cells fully recover by the end of the first week, and more importantly they 
become resistant to the following stress exposures. In the conclusion, based on 
the observed results it takes 1 week for stress recovery, and around 2 weeks to 
adapt an artificial alginate bead environment to their functional niche [202]. 
The niche adaption hypothesis was supported by the expression pattern of 
collagen1A1 gene (Figure 3.4E), the main component of ECM. The first week 
after encapsulation the expression of COL1A1 was decreasing (stress recovery 
time), but after 5 days it started to grow until day 21 when the niche supposedly 
was formed, and cells started its normal activity and proliferation. Thus, these 
results prove the importance of niche in cells adaptation after encapsulation, 
and indicates after the 3rd week of encapsulation cells highly active and most 
favorable for transplantation.  
However, to prove the hypothesis of cells adaptation and recovery within 
3 weeks, the following test experiment was performed, to evaluate cells 
behavior and stress state after being encapsulated and released from the 
artificial matrix within 4 weeks at 8 time points and placed in the minimum 
stress conditions. The results were compared to the control group, cells 
maintained in TCP without being encapsulated before.  
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The evaluation of cell behavior post-encapsulation in 8 experimental and 
control groups supported the above-mentioned hypothesis. Based on the 
obtained results within 9 groups, one group was considered as the most suitable 
for tissue maturation after encapsulation, 28 days in the beads. As it is shown in 
the Figures 4.1-4.7 all vital parameters for the last experimental group met the 
main requirements for tissue fabrication, as it was described above, high 
proliferation level, relatively low death rate, high migratory and communication 
potential, good self-assembly, so as high cell activity level. Group 9 had the 
highest proliferation rate and activity level, beneficial for achieving the proper 
cell number and ECM amount for functional niche formation. So as high level of 
N-cadherin expression from the first day after cells were placed in the control 
conditions. Another important parameter was noticed, is cells were tend to 
grow in tight junctions (Figure 4.7), keeping the memory of being closely placed 
in encapsulated artificial 3D environment. This group also had relatively low 
death rate for apoptosis and necrosis. All these parameters will be beneficial for 
fast and successful scaffold adaption after implantation; moreover it might 
decrease the risk of immune rejection or fibrosis propagation, because of 
homeostatic stability in the fabricated tissue. However, this group had relatively 
high amount of cells in suspension, first and last day of culturing (the same 
pattern was observed for many groups), this peculiar pattern can be explained 
by the ability of these cells to grow in two forms: adhered to the tissue culture 
plates and in suspension.  
The other experimental groups 4-8 recovered after encapsulation stress, 
were not able to meet the tissue fabrication requirements, because of low 
proliferation level, low activity and high cell death rate. Thus, if perform 
fabricated tissue implantation before 4 weeks of maturation, it might cause a 
severe immune reaction, hence rejection or fibrosis of the implanted 
replacement. However, the disadvantages of these groups for organ printing 
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application, can be the advantage for application of these groups as 3D models 
for diseases investigation so as for drug screening.  
3D models currently are highly demanded tools in many different fields, 
such as basic biology understanding, pathology mechanisms evaluation for 
cancer, schizophrenia, Alzheimer's and others [203-212]. Moreover, beauty 
companies need proper 3D models for cosmetics testing. Thus, here is 
considered another application of EHDJ encapsulation system for 3D models 
fabrication for disease molecular mechanisms understanding. The main 
requirement for this application will be functional and stress-less cell state, with 
stable proliferation level.  
According to the obtained results, groups 4-8 will be the most favorable 
for 3D disease models application. Cells by the time of 2-3 weeks are already 
adapting alginate environment to their niche, thus they fully recovered and 
function in their normal regime. The level of N-cadherin is on the control level, 
whereas the proliferation and activity level is lower, mimicking in vivo 
conditions (cell proliferation rate in vitro is accelerated by growth media 
compare to in vivo conditions [211]). The death rate stabilizes to the control 
level after the first day of culturing. By encapsulating modified to a desirable 
disease type cells, within 2-3 weeks it is possible to achieve a good model for in 
vitro investigations.  
Above described application of 3D model for disease molecular 
mechanisms understanding, logically brings the discussion to another 
application, drug screening [212, 213, 214, 215]. Many drugs today fail to reach 
market because of inability to meet necessary requirements during testing steps 
in vitro and in mice, in vivo. Thus, proper in vitro testing on human 3D 
fabricated tissue might significantly improve the process of drugs development.  
Based on the above described application of EHDJ encapsulation system 
for 3D models fabrication, the drug screening can be conducted at any of 4-8 
groups. As it was shown, these groups have viable, functional cells that mimic 
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3D in vivo tissue with relatively low and stable proliferation level and high 
activity what will be perfect for drug screening. Drug screening on 3D models 
have an advantage over 2D cultures, by proper design of 3D models it can 
perfectly mimic targeted tissue, including blood vessels, variety of cell types and 
tissue complexity, which is out of reach in 2D cultures. Over in vivo mice testing, 
3D model can have a benefit as well, because it will mimic human tissue, which 
has differences from mice.   
Thus, the second conducted study presented here, proved that EHDJ 
encapsulation system is safe, easy in manipulation, and suitable for organ 
printing application. The next set of experiments will be focused on tissue 
fabrication, its maturation, in vitro functionality testing and following in vivo 
implantation.   
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4.6 Conclusions 
For successful 3D tissue fabrication, cell homeostasis and niche have be 
to deeply studied and controlled for every tissue engineering method. This 
chapter presents a detailed evaluation of EHDJ encapsulation system effect on 
cell behavior during the maturation process for organ printing application. The 
conducted study, supported the hypothesis presented in the previous chapter, 
cells recover from encapsulation stress within one week, and after they actively 
modify alginate bead microenvironment to their functional niche within 3 
weeks, thus by the end of the 4th week fabricated microbeads were ready for 
implantation. Moreover, there  was described a variety of possible applications 
for EHDJ fabricated beads, such as 3D models for pathologies investigation, so as 
for drug screening.  
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Chapter 5 
Fabrication of complex 3D structures with 
photolithographic encapsulation and following 
magnetic levitational assembly.  
This part of work was conducted during PhD internship under the supervision 
of Prof. Utkan Demirci at Stanford University School of Medicine, Canary Center 
at Stanford for cancer early detection, USA. The results of the conducted study 
resulted in 2 publications: 
 Tasoglu, S., Yu, C.H., Liaudanskaya, V., Guven, S., Migliaresi, C., Demirci, U. 
(2015) Magnetic levitational assembly for living material fabrication. 
Advanced healthcare materials (in press). 
 Namkoong B.*, Guven S.*, Ramesh S., Liaudanskaya V., Abzhanov A., 
Demirci U. Recapitulating cranial osteogenesis with neural crest cells in 
3-D microenvironments. STEM CELLS (Submitted). 
 
5.1 Abstract  
Functional 3D micro tissue fabrication is critical for many fields, such as 
tissue engineering, in vitro models for developmental and molecular biology and 
others. Originally most of the body tissues are complex, composed of variety of 
cell types, with perfectly aligned microunits, like kidney or neural layers of grey 
matter and other unique tissue characteristics. Thus, creation of 3D micro 
tissues in vitro composed of functional micro units, each predetermined with its 
composition, functionality and shape to recapitulate body tissues is challenging. 
In this chapter presented a promissing and simple approach for creation of 
functional living structures with controllable structural, morphological, and 
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chemical features using photolithographic encapsulation system for fabrication 
of small building units and its following assembly into more complex 3D 
structures with magnetic-based levitational method. This strategy allows 
production of functional shape-controllable units with defined structure and 
composition and their alignment in a paramagnetic suspending media into 
complex 3D structure, mimicking natural tissue.  
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5.2 Introduction 
3D micro tissue fabrication in vitro became very important to study cell 
and tissue physiology, moreover as tissue/organ replacements for regenerative 
medicine [201, 217]. 3D microenvironment has a dramatic effect on many cell 
growth parameters, such as diffusion of growth factors or other important 
proteins, stem cells differentiation; moreover, it might also have an impact 
factor for morphological changes over larger scale, such as morphogenesis and 
others [216]. It was also demonstrated that cellular microenvironment plays a 
crucial role in cell phenotype fate orientation, for example, phenotype can 
supersede genotype simply due to interaction with ECM [192]. Culturing cells in 
3D gives a direction for recapitulation of in vivo cell growth.  
 Thus, 3D microtissues have a critical role in tissue engineering for 
transplantation, restoration and recovery of damaged tissues, but also as cancer 
models for molecular analysis in vitro, and as a tool for new drugs efficacy and 
toxicity screening [203-210, 212, 213, 214, 215].  
There were developed several approaches for a successful 3D complex 
tissue fabrication such as top-down and bottom-up [12, 14, 15, 21, 27]. Top-
down approach is widely used in TE, but it does not allow the production of 
geometrically well-defined complex constructs that may cause some difficulties 
such as vascularization of large scaffolds, and 3D spatial orientation of different 
cell types [12]. Bottom-up approach can overpass these problems. In the last 
decade bottom-up approach was deeply investigated and variety of methods 
were developed for successful 3D complex tissue fabrication such as extrusion- 
and lithography-based methods, bioprinting, magnetic, robotic and levitational 
assembly of cell-laden units, cell sheets or aggregates [24, 25, 26, 27, 34].   
Photolithography, is one of the commonly used methods for micro 
tissues fabrication in bottom-up approach, initially it was developed for 
application in microelectronics, however around a decade ago it found an 
application in tissue fabrication. At present, photolithographic encapsulation 
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applied for fabrication of microengineered hydrogels that can be used for 
different purposes, such as 3D models fabrication for structural biology 
research, drug screening, self-assembly methods for tissue engineering and 
many others [67, 68, 69]. This technology became feasible in tissue engineering 
partly because of discovery and development of natural and synthetic photo 
cross-linkable biopolymers [41, 103, 104, 105]. Polymer crosslinking happens 
through exposure to UV light. Generally, thin masks are used to create a 
desirable final shape hydrogels. Masks have to be designed in black and 
transparent parts, in the way just transparent part will allow pass the UV light 
and crosslink the sensitive material. After UV exposure, not cross-linked 
material will be washed away, and just solid hydrogels will be left on the cover 
slip. The final resolution of fabricated hydrogels can be vary from sub microns 
to millimeters. When the average cell size is around 10 microns, thus this 
technology allow encapsulation of high cell densities in microstructures. 
However, hydrogels produced with photolithographic system have 
simple composition that doesn’t mimic the complexity of the natural tissues. 
Thus, small cell-laden units with controlled shape and composition have to be 
assembled into more complex ones. Techniques for aligning and assembling soft 
biological or non-biological components reliably in three dimensions (3D) are 
critical for several current micro/bio-manufacturing processes such as bottom-
up tissue engineering and significant for a range of other applications including 
automated manufacturing lines and inspecting products for quality control 
[217]. In the last decade, there were presented many methods for micro-units 
assembly without guidance, such as fluidic force [218], magnetic force [35, 219-
220], gravity [220] and guided assembly, like railed microfluidics [221], robotic 
assembly [24], acoustics [26], magnetics [35, 133] and others [222, 223, 224, 
225].  
Here is presented contactless and nanoparticle-free approach for tissue 
self-assembly, magnetic levitation. This method is based on the principle of 
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levitating subjects in paramagnetic suspension [35]. Salt ions of gadolinium 
(Gd3+) and magnesium (Mn2+) or radicals have paramagnetic properties, thus 
can be applied for cell-laden units levitation. However, paramagnetic 
suspension might have a toxic effect on cells, thus it has to be evaluated prior 
the tissue fabrication.  
NIH3T3 mouse fibroblasts were encapsulated in photo-crosslinkable 
polymers: modified gelatin (GelMA) and polyethylene glycol diethacrylate 
(PEGDA), or seeded on laminin-coated beads, with following levitational 
assembly in the media suspension with ions of Gd3+ salt. Cells behavior 
parameters were evaluated with Live/Dead and Alamar Blue assays for 
viability, immunocytochemistry to ki67/collagen1/phalloidin to demonstrate 
cells proliferation potential, activity and functionality post-assembly.  
The main goal of this chapter is to demonstrate powerful yet simple 
approach for creation of complex living microtissues with tunable features 
using photolithographic encapsulation system and magnetic levitational 
assembly, moreover, to evaluate the fabrication and assembly processes effect 
on the biological parameters such as cell viability, proliferation and activity. 
Presented approach allows fast fabrication of various shaped hydrogels or cell 
seeded microbeads and following alignment in a paramagnetic suspending 
media into functional 3D microtissues.  
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5.3 Materials and methods  
Cell culture.  
NIH3T3 Mouse fibroblasts cell line was expanded in 25-175-mm tissue-
treated culture flasks as a monolayer at 37°C under 5% of CO2 in high glucose 
Dulbecco’s Modified Essential Medium (DMEM) with 10% fetal bovine serum 
(GIBCO), 2mM Glutamine and 1% antibiotic/antimicotic mixture (Sigma, USA). 
DMEM medium was changed every 3rd day. Cells were cultured to 90-95% 
confluency before encapsulation. 
 
Hydrogel preparation.  
GelMA (gelatin methacrylate) 5% (wt/v) prepolymer solution was 
prepared by first dissolving the photo-initiator (PI) 0.5% (w/v) in PBS. When 
the PI was dissolved completely foam-like GelMA 5% (wt/v) was added and 
dissolved at 80°C.  
PEG (polyethylene glycol) 15 % (w/v), 19.7 % (w/v) and 50 % (w/v) 
PEGDMA 1000 (Polysciences Inc.) were prepared by dissolving PEGDMA into 
PBS. Then, 1 % (w/v) photo-initiator (Igracure 2959, Ciba) was added into the 
mixed solution. The mixed solution was placed into the 80° oven for 20 minutes 
to form prepolymer solution.  
 
Encapsulation by UV crosslinking.  
GelMA: 100 μl of cell suspension in prepolymer solution was placed on a 
cover slip and photo-crosslinking was performed with UV-light intensity of 2.6 
mW/cm2 for 15 seconds for GelMA (Omnicure S2000). 2 mm round with 150um 
thickness cell encapsulated hydrogels were obtained using UV photo mask. Cell-
laden hydrogels were washed with PBS to remove any remaining prepolymer 
solution and submerged in cell culture media after placed in an incubator (5% 
CO2, 37°C).  
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PEGDMA: 300 µl of 15% PEG prepolymer solution was pipetted onto 600 
µm spacer, and exposed under UV light (2.9 W/cm2, 5 cm between the light 
source and prepolymer solution) for 30 seconds to achieve gelation. With the 
same parameters of UV light, for 19.7 % PEGDMA, 600 µl was pipetted, while for 
50 % PEGDMA the volume of pipetted solution was 1.3 ml. Different shapes of 
photomasks were also used for different concentrations. Smallest disk shape 
(r=2 mm) photomask was for 15 % PEGDMA, medium donut shape (inner 
diameter r2=1.5 r) was for 19.7 % PEGDMA, and largest donut shape (inner 
diameter r3=1.1 r2) was for 50 % PEGDMA.  
 
Hydrogels levitation 
After UV crosslinking, three gels with different sizes and shapes were 
picked up carefully and placed into paramagnetic medium within a plastic 
reservoir (3.3 cm x 3.3 cm x 2.7 cm), and a 3 mm thick rectangular PMMA (3.3 
cm x 5 cm) was covered to cap the reservoir. The plastic reservoir was 
connected to a syringe pump (WPI, Programmable Syringe Pump), serving as a 
medium pumping system used after achieving levitation. Cell-laden gels were 
assembled with the levitation set up in 50mM GD solution. The PMMA chamber 
was exposed to magnetic force created by two magnets (same poles facing each 
other), and the distance between the two magnets was 3 cm. During the 
levitation, the 50 % PEGDMA gel would be at the bottom layer, the 19.7 % 
PEGDMA gel would be at the middle layer, and the 15 % PEGDMA gel would be 
levitated at the top layer. After all the gels were levitated and achieved 
equilibrium in the middle of reservoir, the solution draining process was 
started. The flow rate of syringe pump was set as 3 ml/min. Under this flow 
rate, the force created during the withdrawing process would not affect the gels’ 
position.  
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Beads coating with NIH3T3 cells.  
Polystyrene divinylbenzene beads (manufactured) were coated with 
20g/ml laminin for overnight at 4C° to enhance cell adhesion. Laminin-coated 
beads were placed in advanced prepared 24-well plate coated with agarose. 
After the solution of 5 million of NIH3T3 cells in 1ml of DMEM was added to the 
beads and placed at 37C°, 5% CO2. After 2 days beads were seeded with 5 
million cells for the second time. Beads were incubated with cells in total for 5 
days.  
 
Levitation set-up of beads coated with NIH3T3 cells. 
Cell-laden beads were assembled with the levitation set up in 50mM GD 
solution. Total time exposure to GD solution 10 min: beads assembly followed 
by drainage of GD solution. Assembled beads were collected on the cover slip on 
the bottom of the chamber. After assembly beads were crosslinked by 
embedding them in 5% GelMA (0.5% PI) and exposure to UV light with 2.6 
mW/cm2 intensity for 15 sec. After samples were submerged in cell culture 
media and placed in an incubator (5% CO2, 37°C). 
 
In vitro evaluations. 
Viability assay.  
Cell viability was evaluated by fluorescence visualization of samples 
stained with calcein/EthD-1. In brief samples were incubated for 20 min at 37°C 
in a solution of calcein/EthD-1 (2mM calcein and 2mM EthD-1). After that the 
supernatant was removed, the hydrogels were washed 2-3 times with a PBS 
solution. Cell counting was made with ImageJ cell counter plugin. Assembled 
and crosslinked cell-laden beads were submerged to viability evaluation with 
Alamar Blue assay every second day after the levitation. 10% solution of Alamar 
Blue in DMEM was added to samples for 4 hours. After 100 l was taken in 
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triplicate and analyzed using fluorescent reader machine. Beads without cells 
crosslinked with GelMA were used as a BLANK for this assay.  
 
Immunocytochemistry.  
Levitated and crosslinked cell-laden beads/samples were fixed with PFA 
4% for 30 min, after samples were blocked and permeabilized with blocking 
buffer (1% BSA, 0,3 % TritonX in PBS) for 1 hour. Primary antibodies for Ki67 
(Abcam ab16667) and collagen  (Abcam ab6308) were applied for overnight at 
4C°. After PBS washing was performed 3 times for 10 minutes. Secondary anti-
mouse for collagen-1 and anti-rabbit for ki67 antibodies were applied for 1 hour 
at room temperature with following 3 times washing in PBS. At last, DAPI 
solution was applied for 5 min. After washed twice with PBS. Results were 
analysed with the confocal microscope (Leica).   
 
Statistical analysis.  
All statistical analysis was performed with GraphPad Prism 6 software. 
Statistical analysis for more than two groups was carried out using one-way 
ANOVA with Tukey’s post-hoc tests. P<0.05 was considered significantly 
different.  
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5.4 Results and discussion 
There was conducted a set of experiments to evaluate an appropriate GD 
salt concentration and time exposure that will be least harmful for cells but 
suitable for levitational assembly. NIH3T3 cells (10mln cells per 1ml of 
prepolymer solution) were encapsulated in 5% GelMA (gelatin methacrylate) 
hydrogels with diameter of 500m and thickness of 150m (Figure 5.1).  
 
Figure 5.1: Example of GelMA hydrogels for GD salt toxicity evaluation. 
Effect of GD at different concentration and time exposure on cell viability.  
Initially, to understand the range in which GD salt will be safe for cells, 
the following set of experiments was performed. The results of conducted 
experiments are shown in Figure 5.2A-B.  
1. Effect of different GD concentration on the cell viability (Figure 5.1A). 3 
concentrations of GD salt were prepared: 10mM, 50mM, 100mM. Set of GelMA 
hydrogels was prepared straight before test. Hydrogel parameters with 
encapsulated NIH3T3 cells: d=500m, thickness of 150m. Samples were 
exposed to different GD salt concentrations for 10 minutes. 
2. Effect of 50 mM GD salt exposure for different time on the cell viability 
(Figure 5.2B).  Hydrogels were exposed to 50mM GD solution for 5 min, 15 min 
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and 60min. Set of hydrogels was prepared straight before test. GelMA hydrogel 
parameters with encapsulated NIH3T3 cells: d=500m, thickness of 150m.  
Based on the first experiment GD concentration of 50mM was chosen as 
the best working concentration for the levitation and cells viability (Figure 5.2 
A). With increase in GD salt concentration, there was observed an increased rate 
of the cell death. Exposure to 50 mM GD salt for 10 min showed around 95% cell 
viability. Based on the results of the next experiment, there was observed that 
exposure for 1 hour to 50 mM GD salt decreases the viability for almost 40% 
percent, which not desirable for tissue engineering application. Exposure to 5 
and 15 min showed high level of cell viability and suitable for application in 
tissue engineering. Based on the levitational assembly of cell-free hydrogels 
prior the viability experiments, it was observed that 10 min is optimal time for 
all the assembly and gels retrieve.  
All the following experiments for cell-laden hydrogels or building units 
were conducted using 50mM GD salt and time exposure 10 minutes.  
 
Effect of 50 mM GD salt exposure for 10 minutes for long-terms cell 
viability, functionality and activity.  
Levitational assembly was designed for implementation in numerous 
fields including regenerative medicine, cell-based pharmaceutical research and 
tissue engineering. The initial set of experiments proved to be safe for cells 
viability at proper GD exposure conditions, but for mentioned above 
applications long-term post-levitational effect on cells viability and functionality 
as important as immediate.  
At first, cells long-term viability was measured every second day after GD 
exposure with Live/Dead assay. The results of treated samples were compared 
to the control group of cells encapsulated in GelMA hydrogels (in the same 
conditions as studying groups) but were not exposed to GD salt. Results are 
presented in Figure 5.2 C-D.  
108 
 
 
 
Figure 5.2: Cell viability after GD exposure: A) at different concentration; 
B) at different time.  Long-term viability results of 50mM GD treated/not 
treated hydrogels for 10 minutes. Lines connecting individual groups indicate 
statistically significant difference. One-way ANOVA with Tukey’s post-hoc tests, 
*p<0.05, **p<0.01.  
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Next, Gd salt exposed samples were evaluated for expression of cell 
functionality markers: ki-67 and collagen1, which are responsible for 
proliferation potential and extra cellular matrix production, respectively. 
Samples were evaluated for above mentioned markers expression every second 
day after Gd salt treatment. Results are presented in Figure 5.3.  
 
 
 
Figure 5.3: Long-term effect evaluation of GD exposure on cells 
proliferation capacity and ability to produce ECM with immunocytochemistry to 
ki67 and collagen type 1. 
Conducted experiments demonstrated cells stay alive with no significant 
differences from the control group for up to 7 days after GD exposure (Figure 
5.2 C-D), most importantly cells were expressing proliferation marker, and also 
Day 1 Day 3 
Day 5 Day 7 
DAPI ki67 collagen1 
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performed they main function, extracellular matrix production (Figure 5.3) and 
cell niche formation.  
However, during the daily microscope analysis of samples there was 
noticed the difference in cell proliferation rate and behavior between studying 
and control samples. Cells in the control samples proliferated with higher rate 
than in GD treated samples. It was hypothesized that GD salt exposure might 
affect the cells proliferation rate. 
Not-treated     Treated 
 
Figure 5.4: Brightfield images of not treated/treated with GD cell-laden 
5% GelMA hydrogels at days 7 and 14.  
Day 7 
control 
Day 7 
treated
Day 14 
treated
Day 14 
control 
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Thus, the next experiment was conducted to evaluate the time needed for 
full recovery of cells after GD treatment. Gd treated samples were cultured in 
full media in CO2 incubator and compared to the control with brightfiled 
microscope imaging daily, until the similar confluency has been, as it presented 
in Figure 5.4. 
 
Hydrogels self-assembly by the levitation.  
Donut-shape PEG hydrogels were prepared in three different 
concentrations 9,5; 10 and 10,5 (% w/v) as it was described in methods part 
above. And assembled in 50 mM GD in chamber placed between two magnets 
(Figure 5.5).  
 
Figure 5.5: Levitational self-assembly of soft micro-components. 
Concentric assembly of two hollow-disk and a solid-disk PEG gels. 
It took about 2-3 minutes to assemble hydrogels. To retrieve the 
assembled construct GD solution was drained using the syringe pump (5-7 
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minutes). To maintain the assembled construct secondary UV crosslinking with 
PEG was applied.  
To analyze the effect of levitation on viability of assembled samples, 
live/dead test was made before the levitation and immediately after (Figure 5.6 
A).  
 
 
Figure 5.6: A) Live/Dead test before and immediately after the 
levitational assembly. B) Immunocytochemistry assay to ki67 and collagen type 
1 markers. 
Next, assembled hydrogels were maintained for 7 days in full media in 
CO2 incubator and after analyzed for proliferation rate and ability to produce 
extracellular matrix with ki67 and collagen type 1 markers expression.  
As it presented in Figure 5.5 the assembly was performed successfully, 
with precise alignment of hydrogels according to their weight and size. The 
Live/Dead assay of levitated/not levitated samples showed no significant 
differences. Also, we demonstrated the cells were functional with ki67 and 
collagen1 markers expression.  
 
 
 
 
DAPI Collagen1 ki67 
A B 
Collagen1 ki67 
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Levitation of manufactured beads coated with cells.  
To demonstrate the broad application for levitational set-up with units in 
different size and shape, there were prepared cell-seeded beads (described in 
details in methods) and assembled with the levitational set-up (Figure 5.7).  
 
 
 
Figure 5.7: A) Cell-seeded beads before the assembly; B) Beads assembly 
process by the levitational set-up.  
Cells were analyzed for viability and activity with Live/Dead kit, however 
the results were not conclusive. The beads size was large and its original color 
was red, which gave an artificial effect during the results evaluation with 
fluorescent microscope. Live/Dead kit wouldn’t allow the quantification of the 
results. Thus, for viability evaluation of levitated beads Alamar Blue assay was 
used (Figure 5.8). For proliferation and activity evaluation samples were fixed 
at Day 1 and Day 7 and stained with antibodies for ki67 (proliferation marker) 
and collagen type 1 (ECM marker), phalloidin (cytoskeleton) and DAPI (nuclei) 
A B 
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for immunocytochemitry. The results were analyzed with the confocal 
microscope (Figure 5.8).  
Viability assay showed cells were alive after assembly with the levitation 
set up, and also their activity was increasing to the 7th day after the levitation.  
IC results showed cells proliferated and produced niche markers (collagen1 and 
phalloidin). 
 
 
 
Figure 5.8: A) Viability with Live/Dead kit; B) Viability assay with Alamar 
Blue assay; C) Immunocytochemistry at day 1; and D) day 7 to ki67, collagen1, 
phalloidin and DAPI.  
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Based on the conducted experiments, we showed that GD salt has mild 
stress effect on cells depends on the salt concentration and time exposure. Thus, 
before application of this method in tissue engineering, the proper working 
concentration and time exposure has to be evaluated for each specific cell line. 
The experiments with NIH3T3, model cell line has stable resistant phenotype, 
showed that concentration of GD salt higher than 50mM might be lethal, but for 
more sensitive cells like stem cells, this threshold can be lower, so as for the 
time exposure. It was shown that viability of NIH3T3 cell-laden blocks exposed 
to 50mM GD salt for 15 min was comparable to the control samples that were 
not exposed to GD salt. Moreover, there was also analyzed cells functionality 
and activity in long-terms (7 days) with expression of ECM marker collagen1 
and ki67 proliferation marker. Besides observed high level of above mentioned 
markers, it was also observed with brightfield images that cells within 2 weeks 
were adapting to artificial matrix environment and modified it to their 
functional niche which would support their proliferation and activity (Figure 
5.3-5.4). 
There was demonstrated the safety and flexibility of photolithographic 
encapsulation system and following levitational-based magnetic assembly of 
simple building units, moreover, its simplicity in manipulation, so as high level 
of control over the samples fabrication and assembly. The levitational assembly 
approach of photocured cell-laden hydrogels presented here offers a parallel 
precise patterning capability to create 3D complex microtissues [34, 35]. 
Additionaly to levitation of photocrosslinked cell-laden hydrogels, there was 
presented another building block type – cell-seeded beads, which as were easily 
and precisely assembled in complex 3D structures by magnetic levitation, and 
showed high viability, activity, proliferation and functionality levels (Figure 5.8).  
The presented method of patterning and assembly of cell-
encapsulating/seeded micro-components might find several broad applications 
in numerous fields including regenerative medicine, cell-based pharmaceutical 
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research and tissue engineering [24, 33, 36].  
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5.5 Conclusions 
In summary, in this chapter there was demonstrated a strategy for cell-
encapsulating/seeded building units fabrication such as microgels or beads and 
following patterned assembly in a contactless manner into 3D complex 
structure. The presented strategy allows programming of each building block by 
composition, stiffness, elastic modulus, porosity, or cell type and then 
levitationally assembled with other building blocks into complex constructs 
with unique spatially heterogeneous material properties. Moreover, it shows 
high scaling potential, good cell viability and functionality, but also simplicity in 
manipulation and guidance of hydrogels assembly, what makes levitational 
assembly approach very promising for bottom-up tissue engineering. 
Additionally, this strategy can be employed to generate soft living 3D hydrogel 
systems to be used in soft robotics, or heterogeneous microphysiological 
systems for pharmaceutical research and diagnostics.  
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Chapter 6 
General conclusions 
The overall objective of this thesis was detailed evaluation of the effect of 
organ fabrication process on cell parameters, like viability, activity, proliferation 
and ability to maintain homeostasis in artificial 3D environment, moreover 
selection of the best encapsulation conditions for successful tissue maturation. 
The general idea was to analyze cell behavior during the organ printing 
steps on the molecular level. We hypothesized that viability testing immediately 
after encapsulation doesn’t represent the whole picture of the cells state. Thus, 
we designed a detailed protocol to evaluate cell behavior during the all stages of 
tissue fabrication process that included a set of posibile changes on the 
molecular level in cell behavior. Next, for the successful tissue maturation, we 
evaluated the best encapsulation time based on the cells viability, proliferation 
rate, ability to maintain homeostasis, and adapt the artificial environment to 
their functional niche. At last, we developed an easy and safe way to assemble 
simple building units into more complex 3D structures, and proved it to be safe 
for cell behavior.    
Initially, we evaluated the effect of EHDJ encapsulation system on cells 
stress state, viability, activity and proliferation. The results showed, that 
encapsulation process has mild stress effect on cell behavior, but within first 
week of encapsulation cells were able to completely recover, and started to 
modify the artificial alginate environment by production of extracellular matrix 
components. Within the following 2 weeks, we suppose the artificial 
microenvironment was adapted to the cell functional niche, because there was 
observed a drastic shift in cells activity and proliferation.  
Thus, based on the conducted initial study, we hypothesized that the best 
encapsulation time for tissue maturation will be at least four weeks, by that time 
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cells would be recovered from fabrication process stress, and adapt the artificial 
environment for their proper functioning. To prove this hypothesis, we released 
cells from the artificial alginate matrix and reseeded them in control 
environments in tissue culture plates, to evaluate the cells behavior. The 
obtained results supported the hypothesis, and showed that cells encapsulated 
for four weeks had the best parameters and functionality for tissue 
transplantation. There was also suggested a variety of other applications of 3D 
microtissues fabricated with EHDJ method besides the tissue transplantation, 
based on the cell behavior parameters.  
At last, the detailed effect of another encapsulation system (photo-
crosslinking based) was evaluated for safe simple building units preparation, 
and applied in magnetic levitational assembly for fabrication of complex 3D 
structures with controlled composition and design. We presented a safe 
contactless way for tissue self-assembly and its application in different fields of 
science. 
The further research will be focused on the direct soft tissue fabrication, 
like neural, cartiladge or liver and its in vitro functionality testing, followed by in 
vivo transplantation. Additionally, the modification of the artificial 
environments will be made to improve and speed up the tissue maturation 
process.    
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Medicine, Volume 8, Issue Supplement s1, pages 377-378 (PP297). 
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